Abstract
Purpose
To review the responses of the liver to acute and chronic physical activity and to summarize relationships between physical activity and liver health.
Methods
A systematic search of HealthStar/Ovid from 1975 through June of 2013, supplemented by articles from other sources.
Results
351 of 8,010 articles identified by HealthStar/Ovid were supplemented by 92 other papers; after focussing, the review was reduced to 435 citations. Prolonged acute exercise reduces hepatic blood flow, stimulating hepatic glycogenolysis, gluconeogenesis and synthesis of some proteins; however, lipid metabolism shows little change. Glutathione depletion suggests oxidative stress. Enzymes affecting carbohydrate metabolism are up-regulated, and lipogenic enzymes are down-regulated. The main triggers are humoral, but hepatic afferent nerves, cytokines, reactive oxygen species, and changes in hepatic blood flow may all play some role. Regular aerobic exercise training improves blood glucose control during exercise by increasing glycogen stores and up-regulating enzymes involved in gluconeogenesis and carbohydrate metabolism. Resistance to oxidant stress is generally increased by training. Lipogenic enzymes are down-regulated, and lipid metabolism is augmented. Modulations of insulin, insulin-like growth factor, glucagon and interleukin-6 may trigger the adaptive responses to training. Cross-sectional and longitudinal studies show that regular exercise can reduce hepatic fat, but the effect on circulating aminotransferases is unclear and the modality and dose of physical activity optimizing health benefits need clarification.
Conclusions
Regular moderate physical activity enhances liver health. Adverse functional changes can develop if habitual activity is inadequate, and extremely prolonged competitive exercise may also be harmful, particularly under harsh environmental conditions.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The liver is a major body organ that plays a central role in the regulation of carbohydrate and lipid stores, and ensures an adequate supply of metabolites for both vigorous physical activity and the synthesis of muscle and brain tissue (Wasserman and Cherrington 1991; Kjaer 1998; Wahren and Ekberg 2007; Fritsche et al. 2008). It also plays a vital role in metabolizing and/or excreting many unwanted substances from the circulation. However, until recently there has been a relative dearth of literature describing the effects of physical activity upon the liver.
Interest in this question has arisen from the understanding that hepatic fatty infiltration (fatty liver) is independently associated with the metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus, and from emerging evidence of an inverse association between physical activity and the risk of developing fatty liver. The latter topic has been the subject of other reviews, although with five exceptions (Eslami et al. 2009; Socha et al. 2009; Thoma et al. 2012; Keating et al. 2012; Musso et al. 2012), these have been unstructured. The contribution of physical inactivity to the development of fatty liver has been commonly acknowledged, and many authors have recommended exercise programmes or an increase of habitual activity as one element in therapy for this pathology (Table 1). Historically, this reflected a widespread view that lifestyle therapy, including regular exercise, could moderate fatty liver by assisting in weight loss, but more recently there has been a growing perception that regular physical activity in itself can exert beneficial effects upon the liver.
Much less is known about the homeostatic role of the liver during acute and chronic physical activity, even in healthy individuals. Available human studies have generally documented positive effects of acute and chronic exercise on liver glucose homeostasis and overall benefits of exercise training upon lipids and lipoprotein metabolism, including a reduction in hepatic fat infiltration (steatosis). These tissue-level observations have been amplified by rodent investigations showing an association between inadequate habitual physical activity and a down-regulation of the key hepatic enzymes associated with glucose and fat metabolism.
The present review examines gross and cellular responses of the liver to both acute and chronic physical activity, spanning the spectrum from physical inactivity to large volumes of vigorous exercise. The primary intention is to compile the collective research (from rodent to human, and tissue-level to molecular) concerning the acute and chronic effects of physical activity upon the healthy liver, in order to characterize the typical physiological responses of the liver to exercise. The review includes exercise-induced effects on hepatic blood flow and lipid and protein metabolism, with particular emphasis upon the interactions between exercise and glucose homeostasis, the molecular changes underlying these interactions, and their potential triggers. Secondary goals are to examine the patterns of regular physical activity associated with maintenance of normal hepatic function, and to document relationships between inadequate habitual physical activity and abnormalities of hepatic function.
Search techniques and classification of physical activity
The data base of HealthStar/Ovid was scanned from 1975 through June of 2013, using the terms exercise, exercise therapy, exercise training, activity, motor activity and physical activity vs. liver, liver cirrhosis, liver disease, fatty liver, liver failure, liver neoplasms, liver regeneration and liver transplants. This search yielded 8,010 hits. All articles that included a full abstract were examined, and 351 items that were specifically designed to examine the effects of acute or chronic physical activity upon the liver were included. This initial database was supplemented with 92 articles gleaned from reference lists and the authors’ own extensive personal files; 8 reports were eliminated with a subsequent focusing of the review to exclude studies of the gall bladder and biliary tract, thus yielding a total of 435 citations.
For the purpose of this review, we have adopted the international consensus definitions (Bouchard and Shephard 1994) of physical activity (any bodily movement produced by the skeletal muscles and resulting in significant energy expenditure) and exercise (physical activity undertaken purposefully, with the intent of developing physical or physiological condition (e.g. cycling, treadmill running or athletic competition in humans and wheel/treadmill running in rodents)). Semantic descriptions have arbitrarily classed the intensity of effort as: low (30–50 % of\({\dot{\text{V}}}\)O2max), moderate (50–65 % of \({\dot{\text{V}}}\)O2max), vigorous or strenuous (>65 % of \({\dot{\text{V}}}\)O2max), and exhausting (exercise pursued to exhaustion), based on the ranges previously described (Thompson 2010). Prolonged exercise is arbitrarily defined as bouts of 30 min or longer.
Acute effects of moderate endurance exercise
Hepatic blood flow
An acute bout of exercise transiently reduces blood flow to the liver. Estimates of hepatic blood flow in humans are commonly based upon indocyanine clearance. Studies using this technique have shown that blood flow to the liver and viscera decreases by up to 20 % during a brief period of vigorous effort, and even more if exercise is prolonged or is undertaken in a hot environment (Lundbergh and Strandell 1974; Rowell et al. 1964; Rowell 1974; Rowell 1986; van Wijck et al. 2011). There appears to be a dose–response relationship, with hepatic blood flow decreasing progressively as exercise intensity increases towards \({\dot{\text{V}}}\)O2max.
Elimination of indocyanine depends upon both hepatic blood flow and cellular function (Daemen et al. 1989). Thus, it has been argued that this method of measuring hepatic blood flow may be confounded by altered hepatic metabolism during heavy exercise. Nevertheless, the trends indicated by the indocyanine method have been corroborated by studies based on sorbitol clearance; the latter technique has shown blood flow reductions of ~40 % at 40 % of \({\dot{\text{V}}}\)O2max (Busse et al. 2004), of 60–70 % at 60–70 % of \({\dot{\text{V}}}\)O2max (Kemme et al. 2000), and of 83 % during near-maximal exercise (Schoemaker et al. 1998). Although the magnitude of the immediate decrease in hepatic blood flow remains contentious (Froelich et al. 1988; Flamm et al. 1990), observations on human subjects have been confirmed by animal studies, where para-aminohippuric acid and sulfobromthalein were injected into a mesenteric vein, and samples drawn from both portal and hepatic veins (Katz and Bergman 1969; Yano et al. 1996).
On cessation of acute exercise, recovery of the resting hepatic blood flow appears to be rapid and indeed there is some evidence from ultrasound studies of human hepatic portal blood flow that hepatic blood flow exceeds normal resting levels for a few hours following physical activity (Hurren et al. 2011). This may reflect inflammation; arguably, it also serves to replenish glycogen reserves and speed the clearance of triacylglycerol from the circulation (Hurren et al. 2011).
We may thus conclude that although vigorous exercise induces a substantial immediate reduction of hepatic blood flow, this is rapidly reversed during recovery, and there is no evidence of subsequent harm to the liver.
Carbohydrate metabolism
Human experimental studies using the stable isotope technique have demonstrated that liver glucose output is increased during exercise (Ahlborg et al. 1974). This serves to maintain blood glucose levels and contributes to the overall increase in the rate of glucose oxidation that is observed using indirect calorimetry. The rate of glucose oxidation is closely matched to work rate, (Bergstrom et al. 1967; Romijn et al. 1993), although even when exercising at ~50–85 % of \({\dot{\text{V}}}\)O2max, liver-derived glucose contributes considerably less to the total energy requirement than the oxidation of skeletal muscle glycogen (Romijn et al. 1993).
The increased liver glucose output is partly a result of glycogenolysis, particularly during the first hour or more of sustained exercise (Kjaer 1998). However, the relative contribution of hepatic gluconeogenesis to total glucose output increases progressively as work duration is increased, and it accounts for some 50 % of glucose production during physical activity that is prolonged for more than one hour (Suh et al. 2007). Lactate (Shephard 1982; Wasserman and Cherrington 1991; Nielsen et al. 2007), amino acids (released from skeletal muscle through the action of cortisol), and glycerol all contribute to gluconeogenesis during exercise (Rowell 1971). As hepatic glycogen reserves become depleted, the rate of gluconeogenesis is usually insufficient to sustain vigorous exercise, and a decline in the blood glucose concentration can therefore occur unless the work rate is reduced (Ahlborg et al. 1974). Depending upon an individual’s training status and diet, both liver and muscle glycogen reserves can be almost completely exhausted over 90–180 min of vigorous aerobic exercise (Terjung et al. 1971).
In conclusion, exercise significantly increases liver glucose output by way of hepatic glycolysis and gluconeogenesis, making an important contribution to blood glucose control and oxidation during sustained endurance activity. These mechanisms can become exhausted during exercise such as a marathon run that continues for more than 90 min.
Lipid metabolism
Under resting, fasted conditions, the liver accounts for a significant proportion (~40 %) of circulating fatty acid uptake, substantially exceeding the uptake of skeletal muscle (~15 %) (Jensen 1995; Meek et al. 1999). A portion of these fatty acids are converted to ketones or oxidized by the liver and other tissues in the splanchnic vascular bed (Havel et al. 1970; Wolfe et al. 1976). There is also a significant re-esterification of fatty acids to triglycerides in the liver (Klein et al. 1989); the triglycerides can then be secreted as very low density lipoprotein triglycerides (VLDLs).
The liver’s dominant role in disposing of circulating (included ingested) fatty acids is suspended during exercise. Hormonal responses to exercise increase the net availability of circulating FFA during physical activity (Wolfe et al. 1990), but with the ensuing changes in blood flow distribution, the majority of these FFAs are directed to the contracting muscle; their oxidation accounts for most of the whole-body fat that is metabolized during exercise, although there is also a small contribution from intramyocellular triglyceride (IMTG)-derived fatty acids (Romijn et al. 1993). The splanchnic vascular bed accounts for less than 20 % of whole-body FFA uptake during exercise (Wolfe et al. 1990), but the relative partitioning of this uptake between hepatic oxidation and triglyceride synthesis remains unknown. Whilst it is believed that hepatic VLDL-derived fatty acids can be oxidized by skeletal muscle (Kiens 1993), the hepatic release of triglyceride in the form of VLDL remains unchanged during exercise (BØrsheim et al. 1999). The current consensus is thus that VLDL makes a trivial contribution to whole-body fat metabolism during exercise (Helge et al. 2001).
Even a sustained bout of physical activity appears to have little immediate effect upon hepatic lipid metabolism. For instance, endurance-trained men showed no change in proton magnetic resonance spectroscopy estimates of hepatic triglycerides following 90 min of cycle ergometry at 65 % of \({\dot{\text{V}}}\)O2peak (Johnson et al. 2012). Likewise, a 60-min bout of cycle ergometry at 60 % of \({\dot{\text{V}}}\)O2max had no influence upon hepatic lipid metabolism in sedentary women (Magkos et al. 2009). One review also concluded that exercise had no effect upon the hepatic concentrations of total lipids, phospholipids and cholesterol in normally fed rats (Gorski et al. 1990). However, the high levels of circulating fatty acids induced by 60–90 min bouts of exercise led to an increase of hepatic triglycerides 3–4 h post-exercise in both mice (Hu et al. 2010) and human (Johnson et al. 2012) studies. A single 4-h bout of swimming also up-regulated hepatic stearyl CoA desaturase in rats and increased hepatic triglyceride content (Ochiai and Matsuo 2012). Further, exercise to exhaustion increased the hepatic content of the bound form of alpha-lipoic acid (lipoyl–lysine), an important co-factor for many mitochondrial proteins that are active in metabolism (Khanna et al. 1998). On the other hand, a single 3-h bout of exercise to exhaustion decreased the hepatic fatty acid synthase mRNA and enzyme activity induced by a high carbohydrate diet in both normal and diabetic (streptozotocin-treated) rats (Fiebig et al. 2001).
In conclusion, in contrast to its effects on glucose and protein metabolism, an acute bout of exercise has little immediate effect upon hepatic lipid metabolism and it may actually slightly increase hepatic triglyceride content. However, evidence (detailed later) showing up-regulation of hepatic enzymes and an overall reduction in hepatic fat levels with chronic exercise suggests that this is a transient response, with no detrimental effect upon the liver, and that a positive adaptation leading to a reduction of hepatic triglycerides occurs post-exercise and/or with chronic exercise.
Protein metabolism
Sustained exercise can augment the hepatic synthesis of a number of proteins, including albumin and insulin-like growth factor binding protein (IGFBP). The latter binds IGF-1, allowing the growth hormone to act continuously upon the liver in paracrine fashion, producing more IGF-1.
Isotope infusion studies in humans have demonstrated increases in both the fractional (6 %) and the absolute synthesis (16 %) of albumin 6 h after completing a session of vigorous interval exercise (Yang et al. 1998). In rats, an increase in hepatic IGFBP-1 mRNA expression was also observed for up to 12 h following vigorous treadmill running; this response may serve to curtail an excessive muscle glucose uptake immediately post-exercise, thus preventing hypoglycemia (Anthony et al. 2001).
There is also evidence from the determination of arterial–hepatic venous differences in human subjects that the splanchnic uptake of alanine, synthesized and released by the peripheral muscles, is increased 15–20 % during mild and moderate exercise (Felig and Wahren 1971). Presumably, this then serves for gluconeogenesis, a view that is supported by an increase of sweat nitrogen during exercise (Lemon and Nagle 1981).
In conclusion, a sustained acute bout of exercise can increase hepatic protein synthesis, but during prolonged activity, the liver also plays an important role in forming glucose from amino acids that are released from skeletal muscle.
Triggers of changes in hepatic glucose metabolism during exercise
The classical view has been that changes in hepatic glucose metabolism with exercise are largely a consequence of the altered hormonal milieu. Thus, the exercise-induced increase in gluconeogensis is stimulated by an attenuated secretion of insulin (Kjaer et al. 1993) and rising glucagon concentrations (Wasserman et al. 1989). If exercise is prolonged for more than one hour, these changes can be accentuated by declining plasma glucose concentrations (Trimmer et al. 2002) and depletion of hepatic glycogen reserves (Wahren et al. 1971; Peterson et al. 2004). Rising glucagon levels boost the extraction of glucose precursors from the blood, accelerating their conversion to glucose (Wasserman et al. 1989) and also stimulating glycogenolysis (Wasserman et al. 1995). The stimulation of glucagon receptors increases concentrations of cyclic adenosine monophosphate (cAMP), with activation of protein kinase A and extracellular signal-regulated kinase (ERK) (Jiang et al. 2001), and it also amplifies adenosine monophosphate kinase (AMPK) signaling (Berglund et al. 2009).
Somewhat surprisingly, moderate exercise does not cause much change in peripheral glucagon levels; however, this may be because plasma concentrations do not necessarily reflect glucagon levels in the portal vein (Wasserman et al. 1993). During vigorous exercise, catecholamine secretion may also play a regulatory role, either by providing the liver with additional substrate from adipose lipolysis and increased peripheral lactate formation (Wasserman et al. 1991), or by activating hepatic catecholamine receptors and thus mitogen-activated protein kinase (MAPK) (Christensen and Galbo 1983). Against this last hypothesis, hepatic glucose output does not seem to be affected greatly by adrenoreceptor blockade (Coker et al. 1997).
Some correlate of glycogen depletion, albeit changes in concentration of a substrate, a derivative of substrate oxidation, an energy-related compound such as ATP, or an alteration in cell volume, might also trigger metabolic alterations more directly via the hepatic afferent nerves (Lavoie 2002). In support of this view, if glucagon secretion is suppressed, an increased activity of the hepatic sympathetic nerves can be detected (van Dijk et al. 1994). On the other hand, glucose release is unaffected by hepatic nerve blockade (Kjaer et al. 1993; van Dijk et al. 1994), and hepatic denervation did not alter the glycemic response of rats to a brief bout of exercise (Lindfeldt et al. 1993).
Some of the changes seen during exercise may occur independently of both hormones and the autonomic nerves, with muscle-derived interleukin-6, for instance, playing a triggering role (Banzet et al. 2009). There are a number of pointers to an action of IL-6 upon the liver. For example, IL-6 stimulation of hepatoma cells increased their glucose production, and the injection of IL-6 into mice induced a small increase of hepatic phosphoenolpyruvate carboxykinase (PECPK) (Fritsche et al. 2010). Exercised mice also showed an increase of the hepatic chemokine CXCL-1 that attracts neutrophils and is involved in inflammation and wound healing, and muscle-derived IL-6 seems the trigger for this response (Pedersen et al. 2011). Finally, IL-6 may mediate the very large increase of hepcidin, a hormone that inhibits iron uptake, as seen in some athletes following prolonged and strenuous exercise such as a marathon run (Roecker et al. 2005; Peeling 2010).
Exercise might also modify liver function through an increased generation of reactive oxygen species, much as in skeletal muscle (Davies et al. 1982; Koyama et al. 1999; Liu et al. 2000). Certainly vigorous prolonged exercise (particularly if performed under hot and humid conditions) significantly restricts visceral blood flow (Wade and Bishop 1962; Rowell 1971), temporarily depriving the internal organs of an adequate oxygen supply (Shephard 2013), and this could favour the formation of reactive oxygen species. The exercise-induced up-regulation of heat shock proteins in rat studies seems to support this hypothesis (Salo et al. 1991; Kregel and Mosely 1996; Gonzalez and Manso 2004), On the other hand, some researchers have found little evidence of oxidative stress in the rat liver following acute exhausting exercise (Bejma et al. 2000; Ogonovszky et al. 2005), with no changes in the activity of anti-oxidant enzymes (Hoene and Weigert 2010).
There seems no fundamental reason why triggers should differ between humans and laboratory animals, but one issue to remember in interpreting these various findings is that much of the available research has been conducted on rodents, where hepatic glycogen reserves are relatively much larger than in humans (Baldwin et al. 1973; Terjung et al. 1974).
In conclusion, there remain several competing hypotheses concerning triggers to the hepatic adaptations of carbohydrate metabolism during acute exercise. It is unclear whether changes in hormonal milieu, substrate/metabolite concentration, cytokines, reactive oxygen species or associated changes in hepatic blood flow initiate these metabolic changes; further research is needed to decide among these possibilities.
Molecular changes
Information on the molecular changes induced in the liver induced by acute exercise is based almost exclusively on studies of normally inactive rodents (Table 2). An analysis of the hepatocyte transcriptome in mice following 60 min of moderate intensity exercise showed that 352 transcripts were up-regulated, and 184 were down-regulated. Many of these changes affected genes that are important for glycolysis, gluconeogenesis and fatty acid metabolism (Hoene and Weigert 2010). Some of these same genes were activated in skeletal muscle, but the response was generally more marked in the liver. The effect was also transient, disappearing within a few hours of ceasing exercise (Hoene and Weigert 2010; Hoene et al. 2010).
Exercise has consistently led to an up-regulation of gluconeogenic and metabolic enzymes such as glucose-6-phosphatase, pyruvate dehydrogenase, and phosphoenolpyruvate carboxykinase (PEPCK) (Banzet et al. 2009; Hoene et al. 2009), reduced expression of lipogenic enzymes (Griffiths et al. 1996; Fiebig et al. 2001), the induction of metabolic regulators such as insulin receptor substrate (Hoene et al. 2009), and an up-regulation of the genes induced by energy depletion. Cortisol is normally implicated in the activation of hepatic PEPCK transcription. Such an involvement is supported by the greatly attenuated exercise responses in adrenalectomized animals, and by the absence of an exercise effect in transgenic mice with deletion of the glucocorticoid regulatory unit (Friedman 1994).
Another exercise-related change is activation of interleukin-6 type cytokine/cytokine receptor signaling, particularly the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway, which can transmit information from outside of the cell to gene promoters on intracellular DNA (Hoene and Weigert 2010). Exercise was shown to increase the activity of hepatic AMP-activated protein kinase activity several fold in rats and this response was diminished in IL-6 knock-out animals (Kelly et al. 2004); however, it is not yet quite clear how this particular cytokine is involved, since IL-6 deficiency did not impair the induction of metabolic genes by moderate exercise (Fritsche et al. 2010). An acute exercise bout also induced a marked activation of the mitogen-activated protein kinase (MAPK) signaling pathway, which transmits information from receptors on the cell surface to nuclear DNA (Hoene et al. 2010).
There is an up-regulation of the hepatic p53 tumour-suppressing pathway that guards against genome mutation (Hoene and Weigert 2010; Hoene et al. 2010), much as seen in skeletal muscle, particularly following eccentric exercise (Chen et al. 2002; Hoene and Weigert 2010). Exercise also stimulates an increased synthesis of heat shock protein (HSP-72, HSP-73 and of the glucose-regulated proteins 75 and 78) in rat liver (Gonzalez and Manso 2004) with a marked up-regulation of genes associated with a stress response, such as transcription factors of the Fos/Jun-family (Hoene et al. 2010). The only human study available to date confirmed that HSP72 from the hepato-splanchnic viscera increased in the first 2 h following prolonged moderate intensity exercise (Febbraio et al. 2002).
Finally, increased production of the transforming growth factor follistatin has been demonstrated in mouse liver during exercise (Hansen et al. 2011). Follistatin inhibits myostatin, thus encouraging muscle hypertrophy, and it also acts as a growth promoter for hepatocytes (Fuwii et al. 2005). Observations on human subjects during cycling have confirmed that liver is the source of the follistatin during exercise; active muscles do not liberate this substance into the circulation (Hansen et al. 2011).
In conclusion, information on the molecular changes during acute exercise generally conforms with expectations based on the gross biochemical changes, including the up-regulation of metabolic enzymes and a decreased expression of lipogenic enzymes. There is also an up-regulation of systems protecting against gene mutation and heat shock, and an increased formation of transforming growth factors such as follistatin.
Adverse responses to acute exercise
Whilst moderate exercise appears to have little effect upon either the morphological characteristics of hepatic tissue (Latour et al. 1999) or liver function and oxidative stress, histological changes, impaired pharmokinetics, markers of oxidative stress and altered blood levels of hepatic enzymes have been observed after heavy and prolonged exercise (Table 3, particularly if there is associated heat stress (Berg and Keul 1982; Hassanein et al. 1992; Giercksky et al. 1999; Eran et al. 2004; Miura et al. 2010). Such findings all point to adverse changes of hepatic function, which could have negative implications for those participating in prolonged endurance events such as marathon running, distance cycling, and long-distance triathlons. However, information to date suggests that normal liver function is regained, at most within a few days of ceasing exercise.
Histological changes
The histological changes associated with vigorous and/or exhausting exercise have been examined mainly in animals. A very heavy bout of exercise has been shown to cause an inflammatory response, with an increase in peripheral leucocyte count (Kayashima et al. 1995). Exercise that results in hepatic hypoxia can also predispose to central lobular necrosis (Rowell 1971; Praphatsorn et al. 2010). Prolonged exercise to exhaustion has further been shown to induce mitochondrial swelling in hepatocytes surrounding hepatic venules, and oncotic and/or apoptotic necrosis of the hepatocytes in rodents (Yano et al. 1997; Huang et al. 2013).
Impaired pharmacokinetics
The study of pharmacokinetic changes induced by exercise provides further insight into possible disturbances of liver function and health. Most pharmacokinetic investigations have been conducted in human subjects. The elimination of “low clearance” drugs such as acetaminophen, antipyrine, diazepam, amylobarbitone and verapamil is affected primarily by changes in hepatic enzyme activity and biliary excretion (Khazaeinia et al. 2000). Their clearance is largely unaffected by either moderate exercise (Balasubramian et al. 1970; Swartz et al. 1974; Klotz and Lucke 1978; Mooy et al. 1986; Loniewski et al. 2001) or very prolonged low to moderate intensity activity such as 6–9 h of marching (Theilade et al. 1979; Fabbri et al. 1991). In contrast, bouts of vigorous and/or prolonged exercise reduce the elimination of such substances as indocyanine, bromsulphthalein, sorbitol and lidocaine (Mooy et al. 1986; van Griensven et al. 1995), whose clearance rate mainly reflects hepatic blood flow (Rowell et al. 1964; Døssing 1985). There remains a need to examine the effects of vigorous and very prolonged events such as ultra-marathon runs or long course triathlon on hepatic clearance function, particular with respect to low clearance drugs.
Oxidant stress
As with the gross changes observed in lipid and lipoprotein concentrations, significant changes in oxidant status may develop after, rather than during an exercise bout (Koyama et al. 1999). It is therefore important that research studies continue observations sufficiently far into the recovery period to detect such changes. Importantly, as in skeletal muscle, these changes are not necessarily ‘adverse’ per se, as they may be important factors in inducing adaptations to regular exercise (Hoene and Weigert 2010).
Some (Neubauer et al. 2008; Pinho et al. 2010; Turner et al. 2011) but not all studies (Margaritis et al. 1997) in humans have demonstrated a transient increase of oxidant stress following prolonged and/or vigorous exercise. However, none of these studies have examined changes within the liver itself.
Animal studies (Table 4) provide more direct evidence that exhausting exercise causes oxidative stress in the liver. For instance, the hepatic glutathione levels have been shown to fall in rats following exhausting exercise, reflecting a large increase in oxidative metabolism, and a reduced ability to buffer reactive oxygen species (Sen et al. 1992). Increased blood levels of malondialdehyde (MDA, a marker of lipid peroxidation), NOx, and xanthine oxidase have also been shown in mice, accompanied by large increases in serum aminotransferases and lactate dehydrogenase (LDH) (Kayatekin et al. 2002). Relative to control animals, liver samples showed increased neutrophil infiltration and reductions in levels of superoxide dismutase, catalase and glutathione peroxidase (Huang et al. 2008). Other studies of rats have found significant increases in measures of hepatic lipid peroxidation following exhaustive exercise (Turgut et al. 2003; Aydin et al. 2005). There is also a substantial rise in the temperature of hepatic tissue during exhausting exercise, and rodent studies have demonstrated an associated increase in concentrations of 70 and 72 kDa HSPs (Salo et al. 1991; Gonzalez and Manso 2004).
Thus, animal studies support the human inference of increased oxidant stress and increased hepatic concentrations of HSP following heavy exercise, but further research is needed to determine how far such changes are an inherent part of the adaptive response to physical activity.
Serum hepatic enzyme levels
Clinicians frequently evaluate human hepatic function in terms of serum levels of hepatic enzymes. Short periods of acute exercise usually have little or no effect upon such indices (Takahashi et al. 2007; Hammouda et al. 2012). However, in the hours following vigorous and very prolonged exercise such as marathon or triathlon competition, many investigators have found increased concentrations of serum aminotransferases, often accompanied by increased bilirubin concentrations and markers of inflammation such as IL-6 and C-reactive protein, similar to the findings in laboratory animals after prolonged vigorous exercise (Moses 1990; Praphatsorn et al. 2010) (Table 3). The cause of these changes (recent physical activity, hepatic injury, haemolysis, or muscle injury) remains unclear (Kindermann et al. 1983; Koutedakis et al. 1993; Rosales et al. 2008). Confirmation of sustained hepatic malfunction has been sought in decreased plasma levels of albumin, globulin and cholinesterase (Nagel et al. 1990; Wu et al. 2004), although reduced concentrations of these substances could also reflect the influence of increased serum concentrations of interleukin-1 (Nagel et al. 1990). Further information is thus required before we can interpret exercise-induced changes in clinical liver function tests as evidence of hepatic damage.
Summary of responses to acute exercise
Hepatic responses to acute exercise include a decrease in regional blood flow, and an increase of glucose output by way of glycogenolysis and glucogeneogenesis. These changes are exacerbated as the intensity and duration of exercise is increased, and they contribute to maintenance of a stable blood glucose concentration. At rest, the liver is a major site for fatty acid uptake, much of which is re-packaged and secreted as VLDLs. However, during an acute bout of physical activity, possibly as a consequence of reduced hepatic blood flow and increased fatty acid uptake by muscle, the liver adopts a more ‘passive’ role, with no measurable change in liver triglyceride concentrations. Albumin and IGF-1 levels are increased after an acute bout of exercise; they likely have growth-promoting effects and contribute to euglycaemia. Although glucagon and insulin have some regulatory influence, the precise stimuli triggering the changes in hepatic function that maintain blood glucose during exercise remain unclear, as do the underlying molecular adaptations. Changes in catecholamines, intracellular high-energy phosphate concentrations related to substrate availability, reactive oxygen species, cytokines and tissue hypoxia have all been suggested as playing a regulatory role. Understanding these stimuli and the molecular effects of acute exercise is made difficult by a lack of direct human evidence, and potential difficulties in translating rodent findings to an interpretation of human responses. Whilst moderate exercise appears well tolerated by the liver, vigorous and/or prolonged or exhaustive activity may result in inflammation, altered pharmacokinetics, oxidative stress and increases in concentrations of HSPs and serum amino-transferases. Vigorous and/or prolonged exercise can cause a slowing in the elimination of markers dependent upon hepatic blood flow, signs of oxidative stress in both humans and animals, and a transient appearance of hepatic enzymes in the serum. However, there is little evidence of permanent hepatic damage; such disturbances seem transient and possibly contribute to exercise adaptations.
Chronic effects of moderate endurance exercise
As with the acute effects of exercise, we will consider changes in the metabolism of carbohydrates, lipids and protein, and triggers for these changes. We will focus particularly upon the role of oxidant stress, and implications for hepatic function.
Carbohydrate metabolism
It is well known that regular exercise training increases a person’s ability to sustain a higher work-rate during prolonged activity, and to exercise for longer before the onset of fatigue. One component of this change is an enhanced resistance to hypoglycemia during exercise. This is partly a consequence of an increased capacity for skeletal muscle to store glycogen and to oxidize fat at the expense of glucose. Although there is relatively little human data, further ‘glucose sparing’ adaptations likely include an increased resting liver glycogen concentration and a reduced rate of both glycogenolysis and gluconeogenesis at any given intensity of exercise (Coggan et al. 1995; Murakami et al. 1997). Other changes associated with exercise training include a reduced availability of gluconeogenic precursors (lactate and glycerol) at a given volume of exercise, and altered hormonal responses (a higher insulin, and lower glucagon and catecholamine concentrations).
Rodent investigations generally agree with human observations in showing that the glyconeogenic and the gluconeogenic responses to glucagon are enhanced with training (Podolin et al. 2001; Drouin et al. 2004). However, there are some differences in the responses of rats, probably related to the fact that gluconeogenesis accounts for some 20 % of glucose production when humans undertake moderate exercise, whereas in rats the figure ranges from 40 to 70 %. In particular, training increases exercise hepatic glucose clearance in humans, but not in rats (Coggan et al. 1995).
Underlying mechanisms apparently include a normalizing of the ratio of inhibitory to stimulatory guanine-nucleotide binding protein (G protein), and a resultant increase in activity of the “second messenger” adenyl cyclase (Podolin et al. 2001). The increased capacity for glucose output contributes to the ability of trained individuals to sustain higher work-rates and to maintain euglycaemia during exercise (Donovan and Sumida 1990). Moreover, the liver of a trained person has an increased absolute capacity for lactate (Donovan and Pagliassotti 1990) and alanine (Sumida and Donovan 1995) clearance, and associated gluconeogenesis (Sumida and Donovan 1993).
Most, but not all (James and Kraegen 1984), rodent studies have shown increases in activity of the enzymes and signaling molecules involved in both carbohydrate and lipid metabolism following aerobic training (Colombo et al. 2005; Aoi et al. 2011).
In conclusion, aerobic training induces metabolic adaptations in both humans and laboratory animals that help to conserve glucose homeostasis during prolonged exercise, including greater glycogen storage in both liver and muscle, and the sparing of carbohydrate through greater fat metabolism.
Lipid metabolism
The enhanced ability to utilize fat during exercise following regular training is largely a function of adaptations in skeletal muscle (and associated hormonal changes); there is little evidence that the liver contributes to this response. This is perhaps understandable, given the apparently trivial role of the liver in contributing to fat oxidation (via VLDLs) (Helge et al. 2001). Moreover, exercise training blunts the lipolytic hormone response to exercise, so that after training circulating concentrations of insulin and insulin-like growth factor binding protein-1 tend to be higher (Prior et al. 2012), and blood glycerol and FFA concentrations are lower at a given absolute exercise intensity (Martin et al. 1993). These changes further reduce the liver’s role, including its exposure to FFAs. Nevertheless, regular exercise is associated with alterations in lipid/lipoprotein metabolism, and it appears to reduce the amount of triglyceride stored in the liver.
Several studies have examined the effect of regular exercise upon liver fat content (discussed later), and the associated liver mass in rats and mice (Table 8). Most investigators have observed a reduction in liver mass with regular exercise training, although such findings have not been universal (James and Kraegen 1984; Murakami et al. 1997). A limitation of many animal studies is that control animals have lived unnatural lives of physical inactivity and over-eating relative to their natural state, and in consequence differences in hepatic tissue mass between sedentary and exercised animals have varied between investigations. For example, in the study of Yiamouyiannis et al. (1992), rats that were fed ad libitum and given free access to a running wheel also ate more, thus presenting with increased values for total, mitochondrial and cytosolic protein (Yiamouyiannis et al. 1992). The total activity of several enzymes was also increased, although the activity per g of liver or per g of hepatic protein remained unchanged (Yiamouyiannis et al. 1992).
The cardio-protective benefit of regular exercise in modifying circulating lipids and lipoproteins is well documented in both human subjects and experimental animals. Cross-sectional research shows that high-density lipoprotein cholesterol (HDL-c) levels are higher in regular exercisers versus their inactive counterparts (Williams et al. 1981), and HDL-c increases with exercise training interventions (Kelley et al. 2005, 2006; Dressendorfer et al. 1982; Terao et al. 1989). Similarly, exercise training may reduce circulating triglycerides and VLDL secretion (Tsekouras et al. 2008). These benefits are associated with a decreased activity of hepatic lipase (Thompson et al. 1991) and alterations in the levels of other hepatic enzymes involved in HDL-c remodelling (including cholesteryl ester transfer protein and lecithin cholesteryl acyl transferase) (Kraus et al. 2002; Halverstadt et al. 2007).
Inter-individual human differences in lipid responses to training programmes have been traced to a polymorphism in the hepatic lipase gene LIPC -514C-T (Brinkley et al. 2011). However, the relative contribution of acute versus chronic responses to these exercise-induced improvements in lipids and lipoproteins remains unclear (Cullinane et al. 1982; Thompson et al. 2001; Magkos et al. 2007).
Rodent investigations have provided insights into the molecular changes underlying the effects of regular physical activity upon lipid/lipoprotein metabolism. Training sessions reduced hepatic acetyl-coenzyme A carboxylase and fatty acid synthase activity and mRNA (Askew et al. 1975; Fiebig et al. 1998, 2001, 2002; Lavoie and Gauthier 2006). Regular exercise also down-regulated the hepatic gene and protein content of stearoyl-CoA desaturase-1 (SCD-1), the rate limiting enzyme in the biosynthesis of saturated-derived monounsaturated fats that are a major constituent of VLDLs. Further, there was a down-regulation of the microsomal triglyceride transfer protein that plays a key role in the assembly and secretion of VLDL lipoprotein (Chapados et al. 2009), and training increased levels of hepatic mRNA for the ATP-binding cassette transporter A-1 that plays a vital role in membrane transport and plasma HDL cholesterol remodeling (Ghanbari-Niaki et al. 2007). Changes in the composition of hepatic phospholipids following training likely have implications for membrane properties, cell signalling and gene expression (Petridou et al. 2005).
In conclusion, exercise training increases muscular oxidation of fat and leads to molecular changes of hepatic function that reduce liver fat content and enhance the blood lipid profile.
Protein metabolism
An expansion of plasma volume is a well-recognized adaptation to regular exercise; expression of the hepatic albumin gene mRNA facilitates this response by increasing serum albumin concentrations, and rodent studies indicate that such an adaptation can occur within days of the initiation of training (Bexfield et al. 2009).
Endurance training also increases the hepatic production of heat shock proteins and decreases the secretion of orixogenic proteins. Thus, endurance training in mice increased hepatic 70 kDa HSP (Mikami et al. 2004) and HSP72 (Atalay et al. 2004) expression in both the liver and other tissues, and the expression of hepatic orixogenic Agouti-related protein was reduced in rats after training (Ghanbari-Niaki et al. 2009); the latter change likely reduces the animals’ appetite.
Triggers of hepatic responses
Both changes in the concentrations of hormones (insulin, glucagon and oestrogen) and cytokines (IL-1-β, IL-6, IL-10 and IGF-1) and altered tissue sensitivity to these agents may contribute to the changes of hepatic metabolism observed following aerobic training.
Hepatic insulin sensitivity was increased in some animal studies. Regular exercise reduced the hepatic mRNA level and protein content of hepatic PEPCK, thus contributing to the improved insulin sensitivity (Chang et al. 2006). However, training has not enhanced hepatic insulin sensitivity in all human studies (Hickman et al. 2004).
A week of repeated bouts of swimming reduced the liver fat content of male rats (Hu et al. 2000; Peijie et al. 2004). Regular training also increased the hepatic glucagon receptor density and glucocorticoid receptor count in exercise-trained rats (Légaré et al. 2001); an increased availability of glucagon may be important to this effect of exercise training, since liver fat was not reduced in animals that lacked glucagon receptors (Berglund et al. 2011).
Hepatic oestrogen receptors appear to influence the effects of exercise training on hepatic lipid metabolism (Paquette et al. 2007). Ovariectomy predisposes rats to hepatic steatosis, an increase of inflammatory biomarkers (e.g. inhibitor-κB kinase β and interleukin-6), an increased activity of hepatic lipogenic enzymes (e.g. sterol regulatory element-binding protein-1c, acetyl-CoA carboxylase (ACC) and stearoyl CoA desaturase), and a decreased expression of enzymes related to fat oxidation (e.g. carnitine palmitoyltransferase and hydroxyacyl-CoA-dehydrogenase). With the exception of increases in ACC, these adverse changes could be reversed, at least in rats and mice, through regular exercise (Jackson et al. 2011; Pighon et al. 2011; Domingos et al. 2012). Carnitine is an important co-factor for the oxidation of both long-chained fatty acids and carbohydrate, and may itself play an important role in the hepatic response; regular exercise attenuates the high-fat diet-induced reduction in carnitine palmitoyltransferase I activity (Cha et al. 2003), and up-regulates the genes involved in hepatic carnitine synthesis and uptake (Ringseis et al. 2011). Training also increased gene expression of microsomal triglyceride transfer protein and diacylglycerol acyltransferase-2 in ovariectomized rats, with a reduction in hepatic triglyceride content (Barsalani et al. 2010).
Some studies have observed greater serum levels of free IGF following aerobic training, either via increased hepatic IGF production (Prior et al. 2012), or because of increased hydrolysis of the corresponding binding factor (Schwarz et al. 1996). Resistance training likely has a similar effect (Bermon et al. 1999). On the other hand, a combination of regular exercise and a low fat diet increased serum concentrations of IGF-1 binding protein, thus decreasing circulating levels of free IGF-1, both in rats and in humans (Nishida et al. 2010; Wieczorek-Baranowska et al. 2011).
Rodent studies have suggested that regular aerobic exercise training may decrease tissue levels of the inflammatory cytokines IL-6 (Moon et al. 2012b) and IL-1β (de Araújo et al. 2012), and increase levels of the anti-inflammatory cytokine IL-10 (with an associated decrease in hepatic apoptosis) (de Araújo et al. 2012). Whilst there is some evidence from human investigations demonstrating a net hepato-splanchnic uptake of IL-6 during moderate intensity exercise (Febbraio et al. 2003), it remains to be determined whether the liver is merely clearing this cytokine from the circulation, or whether it has a specific role in glucose homeostasis.
In conclusion, a variety of triggers have been suggested for the adaptations of hepatic metabolism associated with exercise training, including alterations in concentrations of and sensitivity to hormones (glucagon, insulin, oestrogen and IGF) and cytokines (IL-1β, IL-6 and IL-10); further research is needed to determine which are important factors, and which are incidental consequences of the observed adaptations.
Role of oxidant stress
Oxidant stress reflects a disequilibrium between the protein load and the ability of the hepatocyte endoplasmic reticulum to fold and assemble proteins correctly. It can be caused either by aging or by severe exercise, with an increased production of superoxides, a decrease of buffering agents, and/or a decrease of peroxidases. In rats, prolonged bouts of vigorous exercise (2 h swimming/day for 3 months) led to a down-regulation of cytosolic aconitase, a key factor in cellular iron homeostasis (Ho et al. 2001), possibly because of an increased production of NO and oxidative stress.
Most studies of mice, rats and dogs (Table 4) have shown moderate aerobic training as minimizing oxidative stress. Markers of oxidative stress are decreased (Navarro et al. 2003), and the activities of hepatic antioxidant enzymes such as superoxide dismutase (Gore et al. 1998; Burneiko et al. 2006; da Silva et al. 2009) and the corresponding signaling molecules (Huang et al. 2010) are increased. Further, hepatic glutathione transferase S activity and concentrations of reduced glutathione are increased (Sen et al. 1992; Radak et al. 2004), and the gene expression of unfolded protein response markers is enhanced (Chapados and Lavoie 2010).
Nevertheless, a few investigators have found no change or even a decrease of anti-oxidant enzyme activity following heavy endurance training (Hong and Johnson 1995), with a decreased hepatic superoxide dismutase mRNA, but an increase of catalase mRNA (Wilson and Johnson 2000), and [contrary to early observations on isolated hepatocytes (Eklöw et al. 1984)], little relationship between anti-oxidant enzyme levels and local oxidant stress (Ji et al. 1990; Godin and Garnett 1992).
Thus, we may conclude that moderate exercise training reduces hepatic oxidant stress, but very heavy training may have adverse effects upon oxidant status.
Functional activity
It is unclear from human studies of serum enzyme levels and pharmacokinetics how far liver function is influenced either by habitual physical activity or by regular low to moderate intensities of exercise training. Nevertheless, the traditional clinical markers of hepatic function (serum ALT and GGT levels) do show a negative correlation with habitual physical activity (Robinson and Whitehead 1989; Nilssen et al. 1990; Pintus and Mascia 1996), probably because a sedentary lifestyle predisposes to steatosis (Whitfield 2001). Whether there is a more direct relationship between physical activity level, fitness and serum aminotransferase levels is discussed below.
In terms of pharmacokinetics, exercise training did not alter creatinine clearance in boxers (Saengsirisuwan et al. 1998), or the pharmacodynamics of propranolol in sedentary subjects (Frank et al. 1990; Panton et al. 1995). Likewise, cross-sectional research showed no significant differences in aminopyrine metabolism, galactose elimination, or indocyanine green clearance between endurance runners and relatively sedentary medical students (Ducry et al. 1979).
However, other reports suggest that hepatic function may be enhanced by vigorous (but not exhausting) training (Døssing 1985). Thus, the clearance of antipyrine (which depends almost exclusively upon hepatic metabolism) was faster in athletes than in controls, with no difference between sprinters and endurance competitors (Orioli et al. 1990). Likewise, endurance runners had a faster clearance of antipyrine than sedentary but otherwise healthy men (Villa et al. 1998). Longitudinal evidence supports these cross-sectional inferences. Three months of exercise training increased the clearance of antipyrine and aminopyrine in previously inactive students; moreover, individual improvements in these indices correlated highly with gains in \({\dot{\text{V}}}\)O2max, which averaged 6 % (Boel et al. 1984). Three months of moderate intensity exercise (combined aerobic and resistance training) also increased antipyrine clearance in elderly women (Mauriz et al. 2000).
Animal experiments generally confirm the beneficial effects of regular exercise on liver function seen in human subjects. Five weeks of training increased antipyrine clearance in mares (Dyke et al. 1998), and the livers of regularly exercised rats had a greater ability to metabolize and excrete certain chemicals not normally found in the body, such as naphthol and styrene products (Yiamouyiannis et al. 1992) and halothane (Daggan et al. 2000). In the study of halothane toxicity, hepatic glutathione levels were unchanged by 10 weeks of treadmill exercise, and it remained unclear whether benefit was due to enhanced anti-oxidant defence mechanisms or the associated decrease in hepatic fat (Daggan et al. 2000).
A further factor increasing the liver’s ability to eliminate some substances is an increased secretion of biliary transporters. Chronic exercise such as swimming or running augments the hepatic production of bile acids (Frenkl et al. 1980) and increases the availability of bile acid transporters (Yiamouyiannis et al. 1993). These changes may accelerate biliary clearance (but not necessarily blood stream clearance) of substances such as indocyanine green (Yiamouyiannis et al. 1993) acetaminophen and antipyrine (Frenkl et al. 1980).
Thus, the general impression from studies of pharmacokinetics is that regular moderate exercise enhances the functional clearance capacity of the liver.
Summary of responses to chronic exercise training
Regular exercise training increases liver glycogen storage and the hepatic capacity for glucose output. On the other hand, glycogenolysis and gluconeogensis are reduced at a given work-rate after training, with a reduced availability of gluconogenic precursors. The net effect is an improved ability to maintain euglycaemia, probably triggered by changes in hormone concentrations and sensitivity. Regular exercise training appears to reduce overall liver mass and associated fat mass, with an increase in HDL-c levels. Hepatic albumin and HSPs increase, and orixogenic proteins decrease with regular exercise training. The precise triggers for these changes of hepatic function are contentious, although hormones (insulin, glucagon and oestrogen) and a number of cytokines appear to be involved. Most (but not all) studies suggest that regular exercise training reduces markers of oxidative stress and increases antioxidant enzyme levels in the liver. Evidence for the overall effect of exercise training in terms of serum aminotransferase levels is conflicting, but most cross-sectional and longitudinal research indicates an improvement of hepatic clearance function with regular exercise.
The role of physical activity in liver disease
In the final section of this review, we will examine interactions between physical activity and certain chronic liver conditions, including non-alcoholic fatty liver disease (NAFLD), hepatic inflammation and cirrhosis, and hepatic carcinoma, considering specifically the roles of inadequate habitual physical activity and co-pathologies in the genesis of these syndromes. We will also examine the impact of exercise training upon liver fat, as seen in both cross-sectional and longitudinal studies, and will finally consider appropriate exercise dose recommendations for the treatment of these disorders.
Non-alcoholic fatty liver disease (NAFLD)
NAFLD is characterized by the accumulation of fat in hepatocytes in the absence of excessive alcohol consumption. The liver normally contains some fat (the triglycerides stored in hepatocytes), but NAFLD is commonly diagnosed when fat stores exceed ~5 % of hepatic mass. NAFLD accounts for the majority of liver disease worldwide; the condition is thought to affect up to one-third of adults (Browning et al. 2004; Szczepaniak et al. 2005) and it is found in most individuals who are obese (Bellentani et al. 2000). Even in children, the prevalence of NAFLD ranges from 2.6 to 9.6 %, depending upon age, sex, ethnic group and habitual physical activity (Takahashi and Fukusato 2010; Tsuruta et al. 2010). Liver biopsy and histological assessment provides the gold standard for the diagnosis of NAFLD, but in human research studies the liver fat content has more commonly been inferred from proton magnetic resonance spectroscopy or CT scan, and in animal experimentation the usual approach has been tissue analysis at sacrifice.
Hepatic fat accumulation is commonly associated with obesity, cardiovascular disease and diabetes. The build-up of triglycerides in the liver could reflect an increased delivery of fatty acids either from adipose tissue or directly from the diet, increased de novo hepatic lipogenesis, decreased hepatic fatty acid oxidation, or a decreased exit of fatty acids from the liver. The first of these mechanisms is probably the most important (Katsanos 2004); it accounts for the major fraction of fatty acids incorporated into liver fat in obese individuals under fasting conditions (Donnelly et al. 2005). The increase in hepatic fat may impair the insulin sensitivity of the hepatocytes (above), and insulin resistance is also manifest in adipose tissue (Kotronen et al. 2008), so that any given secretion of insulin is less effective in reducing lipolysis (Korenblat et al. 2008).
NAFLD can progress from a simple accumulation of fat through inflammation (steato-hepatitis) to fibrosis, cirrhosis and liver failure and even hepatic carcinoma (Angulo 2002). It is not entirely clear why the condition remains a simple steatosis in some individuals, but shows a progression of pathology in others. Inter-individual differences in reactions to reactive oxygen species, cytotoxic dicarboxylic acids, and hormonal balance, as well as mitochondrial abnormalities may be involved (Angulo 2002). Progression from simple steatosis to steatohepatitis probably reflects the combined effects of hepatic fat accumulation and oxidative stress, possibly exacerbated by endoplasmic reticulum stress (Malhi and Kaufman 2011) and gut barrier dysfunction (Rao 2009); anti-oxidant therapy is not necessarily helpful in preventing disease progression (Nobili et al. 2008).
Hepatic inflammation and cirrhosis
There is relatively little research evidence concerning interactions between physical activity and the more advanced stages in the spectrum of NAFLD. From available information, it could be suggested that physical activity has some direct positive influence on hepatic pathology beyond simply modifying liver fat levels. For instance, as fibrosis develops, markers of hepatic apoptosis [plasma cytokeratin 18 (CK18) fragments, soluble Fas (sFas), and sFas ligand (sFasL)] increase (Fealy et al. 2012), and these changes have been positively associated with physical inactivity (Lee et al. 2008).
The situation can become a vicious cycle, since any form of hepatitis may discourage physical activity. Individuals affected by chronic hepatitis C infection were found to be less active than their peers, and to engage in less vigorous activity (Moon et al. 2012a). The intensity of physical activity seems important in preventing disease progression, since in a large adult cohort with biopsy-proven steatosis, neither total reported exercise per week nor the duration of moderate physical activity was associated with either the risk of steatohepatitis or the histological stage of fibrosis. On the other hand, meeting the weekly vigorous physical activity recommendation reduced the odds of steato-hepatitis to 0.65, and spending double the recommended time in vigorous activity also reduced the odds of advanced fibrosis to 0.53 (Kistler et al. 2011).
Three months of moderate intensity exercise therapy (5 days/week) lowered serum amino-transferases (ALT and AST) in patients with cirrhosis (Baba et al. 2006), and as little as a week of vigorous exercise training was sufficient to decrease ALT and CK-18 fragments (Fealy et al. 2012). Nevertheless, the primary rationale for advocating exercise therapy in patients with advanced liver disease is arguably for the multiplicity of other benefits of chronic exercise, especially those relating to physical weakness and co-morbidities. Thirteen studies of patients with hepatic cirrhosis noted substantial decreases in aerobic capacity and muscular strength relative to healthy controls (Jones et al. 2012). Low levels of aerobic fitness and exercise tolerance (Wiesinger et al. 2001; Pieber et al. 2006; Dharancy et al. 2008) have been confirmed in other studies (Ritland et al. 1982, 1983; Campillo et al. 1990a, b; DeLissio et al. 1991; Terziyski et al. 2008), particularly in individuals with associated ascites (Campillo et al. 1990b; Wong et al. 2001). There is also evidence of muscular weakness (Tarter et al. 1997; Andersen et al. 1998), proportional to the severity of disease, but independent of its etiology (Campillo et al. 1990b; Wiesinger et al. 2001; Terziyski et al. 2008).
Thus, exercise that includes an element of resistance training is arguably a useful therapy for improving fitness and functional capacity in this population, but it remains unclear whether exercise can restore liver health (and if so, the dose that is needed). One major obstacle to implementing and sustaining a programme of exercise training in advanced liver disease is initial fatigue; this has an adverse effect upon the individual’s quality of life (Stanca et al. 2005), and by discouraging physical activity, it progressively exacerbates the initial loss of muscular strength (Wu et al. 2012). Nevertheless, a programme of regular progressive exercise can counter fatigue, even in people with advanced fibrosis (Zucker 2004). Moreover, given adequate motivation, patients with cirrhosis can tolerate quite vigorous exercise, maintaining oxygenation of the brain and muscles (Bay Nielsen et al. 2005) and showing no evidence of hypoglycemia while they are active (DeLissio et al. 1991). The one major concern in this condition is the potential to develop oesophageal bleeding. The hepatic venous pressure gradient is increased even at low levels of physical activity (30 % of peak work-rate) (Garcia-Pagan et al. 1996), and in patients with oesophageal varices, portal hypertension induced by over-vigorous exercise could cause such bleeding.
There have been few investigations of the effect of aerobic training in hepatic cirrhosis. One investigation reported a 29 % gain of predicted \({\dot{\text{V}}}\)O2max over 10–12 weeks of training (Ritland et al. 1983), and a second trial with only four subjects found an increase of \({\dot{\text{V}}}\)O2max in two of the four individuals, with an 18–20 % improvement of muscle strength in these two individuals (Campillo et al. 1990b).
Animal studies of exercise and liver pathologies
Animal studies have underlined the potential of exercise to have direct beneficial effects upon the diseased liver. In one such study, mice were fed a high-fat diet; however, those animals that subsequently underwent a progressive 16-week aerobic exercise intervention showed an elevation of hepatic tumor necrosis factor levels, together with a reduction or abolition of macrophage infiltration and signs of fibrosis (Sirius red and -smooth muscle actin staining and tissue inhibitor of matrix metalloproteinase-1 mRNA) (Kawanishi et al. 2012). A second investigation noted signs of inflammation and steatohepatitis (macro-vesicular steatosis and lymphocytosis) in sedentary rats that were fed a high-fat diet, but such findings were greatly attenuated in their peers who exercised daily; ALT but not AST levels were also reduced in exercised animals (He et al. 2008).
We may thus conclude that exercise programmes have favourable effects in advanced hepatic disease, provided that patients can be motivated to sustain such activity.
Hepatocellular carcinoma
There has been a paucity of research into interactions between physical activity and hepato-cellular carcinoma. A 10-year follow-up of study of 507,897 retired Americans found a significantly reduced risk of hepatic carcinoma in those who were regularly active (>5 times a week) vs. those who reported exercising never or rarely (odds ratio 0.64) (Behrens et al. 2013). A moderate exercise programme may be beneficial, even if the hepatic carcinoma is quite advanced. One case report noted an increase in aerobic capacity after 6 weeks of supervised aerobic exercise therapy (Crevenna et al. 2003).
The influence of other pathologies associated with inadequate habitual physical activity
The vast majority of research concerning physical activity in the aetiology and management of liver disease has focused on simple hepatic steatosis (detailed below). However, NAFLD is commonly associated with other markers of inadequate habitual physical activity, including cardiovascular disease, metabolic syndrome and type 2 diabetes mellitus. In terms of associated insulin sensitivity, univariate correlations suggest that although body fatness is a prime determinant of whole-body insulin sensitivity, the main determinant of hepatic insulin sensitivity may be the individual’s active energy expenditure (Holt et al. 2007). A follow-up of 6,003 patients with non-alcoholic fatty liver disease found 411 developed type 2 diabetes over a follow-up averaging 4.9 years; a Cox proportional hazards analysis demonstrated that a gamma glutamyl transferase (GGT) >109 IU/L and an exercise level of less than 60 min per week were significant predictors of diabetes, both with hazard ratios averaging 1.60 (Arase et al. 2009). GGT facilitates the intracellular transport of glutathione, and increases in levels of this enzyme are a possible indicator of oxidative stress, which in turn can predispose to diabetes (Nannipierri et al. 2005).
Whilst it has been thoroughly documented that low levels of habitual physical activity predispose to the obesity, dyslipidaemia, impaired glucose tolerance and high blood pressure that characterize cardiovascular disease, the metabolic syndrome and diabetes, and that a physical activity intervention is effective in their management (Winnick et al. 2008), fat reduction in the liver is also an important component of both prevention and treatment. A decrease of hepatic fat content has been thought to avert type 2 diabetes mellitus, particularly in older individuals (Tamura et al. 2005; Thamer et al. 2007). Similarly, a normalizing of liver fat content in patients with type 2 diabetes improves the insulin-induced suppression of hepatic glucose output and restores normal fasting blood glucose concentration (Petersen et al. 2005). Recent research interest has thus centred on the role of NAFLD in these pathologies, and the effect of physical activity on liver fat levels.
The association between habitual physical activity/fitness and liver fat (cross-sectional studies)
A possible role for exercise therapy in the management of NAFLD is supported by many cross-sectional investigations that show an association between low levels of habitual physical activity and/or fitness and the prevalence of NAFLD. Sixteen such studies of human subjects have made cross-sectional assessments of habitual physical activity (Table 5); 12 used physical activity questionnaires, three used objective activity monitors (Newton et al. 2008; Fintini et al. 2012; Gerber et al. 2012), and one classified subjects based upon their obesity (Viitasalo et al. 2012). Sample size ranged from small groups to populations >30,000, and one analysis was based upon twins with dissimilar activity patterns (Leskinen et al. 2009). In one instance, objective monitoring suggested an effect of physical activity, but (probably because of lesser reliability and validity) subjective questionnaires completed by the same individuals did not (Fintini et al. 2012). Collectively, these studies showed that habitual physical activity was an important correlate of hepatic fat in most comparisons, with a possible exercise volume-response relationship (Hsieh et al. 1998), although two reports found no relationship between the severity of histological abnormalities and physical activity (Kang et al. 2006; Kistler et al. 2011).
Eleven reports [including the one twin study (Leskinen et al. 2009)] related cycle ergometer or treadmill assessments of aerobic fitness to hepatic fat accumulation (Table 6). With two exceptions (Seppala-Lindroos et al. 2007; Krasnoff et al. 2008), an inverse relationship was seen. However, in some studies the negative association was relatively weak (Nguyen-Duy et al. 2003; McMillan et al. 2007), particularly if data were co-varied for inter-individual differences in obesity.
Physical activity interventions and liver fat (longitudinal trials in humans)
Forty-six longitudinal human trials were identified (Table 7). Often, sample sizes were small; 19 trials included some form of non-exercise control group, often “usual treatment” or a dietary regimen. Interventions ranged from general lifestyle recommendations to specific programmes with careful control of both exercise and diet. Programmes typically yielded consistent reductions in liver fat, and this was usually associated with decreased insulin resistance. One report noted an improvement of histopathology in response to a combined exercise and weight loss programme (Goodpaster et al. 2010), but there is little evidence in this regard. Effects on serum aminotransferase levels have also been unclear, possibly confounded by normal or near-normal levels in the studied cohorts prior to interventions (Keating et al. 2012; Thoma et al. 2012).
It seems likely that benefits such as a reduction of hepatic fat and a possible normalization of serum aminotransferases will be maximized by a combination of physical activity and dieting which results in significant weight loss, but the respective contributions of diet, physical activity and weight loss to improvements in hepatic function remain to be defined (Thoma et al. 2012). Exercise has traditionally been employed with the goal of weight loss, but some investigators have found benefits from exercise in the absence of dieting (Larson-Meyer et al. 2008) or any change in body mass (Johnson et al. 2009). Further, benefits have persisted after statistical adjustment of data for changes of body mass (Bonekamp et al. 2008). Moreover, at least one study found that dietary manipulation did not enhance the effects of exercise (Eckard et al. 2013).
Nevertheless, much of the current evidence suggests that exercise training may, at best, enhance the hepatic effects of dieting (Goodpaster et al. 2010), and may (Coker et al. 2009) or may not (Tamura et al. 2005; Shah et al. 2009) further increase the insulin sensitization induced by dieting. Significant weight loss (10 %) seems the most effective means to lower liver fat content and aminotransferase levels; lesser effects are seen in studies where the decrease in body mass was 5 % or less (Chen et al. 2008), or if exercise did not induce weight loss. Several reports have found that although exercise has other benefits, such as insulin sensitization, it does not enhance the hepatic response to dieting (Tamura et al. 2005; Shojaee-Moradie et al. 2007; Shah et al. 2009; van der Heijden et al. 2009, 2010b; Jenkins and Hagberg 2011; Straznicky et al. 2012).
Most investigations have evaluated aerobic training programmes. A few reports have also noted favourable responses to resistance exercise training, although its effectiveness in NAFLD is less clearly established. Two of three comparisons between aerobic and resistance training (Lee et al. 2012; Bacchi and Moghetti 2013) found similar decreases of hepatic fat with both types of exercise. However, the third and largest study found no benefit from resistance training alone, and the response to aerobic training was not enhanced by adding resistance activity (Slentz et al. 2012). Another study of a resistance exercise programme found no reduction of inflammatory markers (Levinger et al. 2009), and one 12-week trial of resistance exercise found a decrease of insulin resistance without a change of hepatic fat content (van der Heijden et al. 2010a). In contrast, a controlled 3-month trial in obese adolescent boys found that thrice weekly 60-min sessions of either aerobic exercise or resistance exercise reduced liver fat, but only resistance exercise was effective in increasing insulin sensitivity (Lee et al. 2012). It is plainly as yet unclear and important to resolve how effective resistance training is for decreasing steatosis and associated comorbidities, particularly as it has been suggested that resistance exercise is important to correct the muscular weakness and autonomic dysfunction that is often associated with this condition (Jakovljevic et al. 2013).
Physical activity interventions and liver fat (longitudinal trials in animals)
Some 21 animal studies of exercise and hepatic steatosis generally confirm the findings of human longitudinal investigations (Table 8). They provide growing empirical evidence that fat accumulation has direct adverse effects upon hepatic function, and that these changes can be reversed by exercise; further, they add helpful information on cellular mechanisms underlying the adverse effect of hepatic fat upon glucose homeostasis (Table 9).
In mice fed a high-fat diet, regular exercise reduced the accumulation of fat in the liver, improved insulin resistance and reduced circulating cholesterol, triglycerides, and AST and ALT levels (Marques et al. 2010). Dietary restriction, voluntary wheel running and imposed swimming or treadmill running all seem effective in preventing steatosis (see Table 8 for references), and in one report hepatic benefits were elicited more readily by intermittent swim training than by continuous bouts of swimming (Sene-Fiorese et al. 2009). Yasari et al. (2006) found that after 6 weeks of detraining, rats trained on a treadmill for 4 weeks had regained a similar body fat to sedentary animals, although liver lipid infiltration was not increased with cessation of training. In contrast, Linden et al. (2013) found that 4 weeks of inactivity following 16 weeks of wheel running caused the development of hepatic steatosis in obese rats, although liver triglycerides were still 60 % lower than in animals that had remained sedentary throughout.
Among mechanisms underlying the adverse effect of hepatic fat upon glucose homeostasis, lipid accumulation appears to down-regulate phosphatidylinositol 3-kinase, an enzyme that has a central role in mediating the action of insulin in hepatocytes (Katsanos 2004). Rats fed an obesity-inducing diet not only developed peripheral insulin resistance, but also demonstrated endoplasmic reticular stress in both hepatic and adipose tissues, with activation of the proinflammatory molecules c-jun N-terminal kinase (JNK) and nuclear factor kappa-B (NF-κB).
Cellular adaptations associated with the benefits of enhanced activity have included increased hepatic mitochondrial fatty acid oxidation, enhanced oxidative enzyme function and protein content, and suppression of de novo lipogenesis (Rector et al. 2011). Specific molecular mechanisms identified as contributing to attenuation of fat accumulation and/or reversal of steatosis have included increased hepatic mitochondrial activity (citrate synthase, β-hydroxyacyl-dehydrogenase [HAD] and cytochrome c oxidase) and subsequent beta-oxidation (Rector et al. 2011), a decrease of regulatory element-binding protein-1c (SREBP-1c, one of a group of transcription factors regulating the genes involved in cholesterol and fatty acid synthesis) (Cintra et al. 2012), down-regulation of the hepatic SCD-1 gene, and thus of SCD-1, a rate-limiting enzyme in the biosynthesis of monounsaturated fats (Yasari et al. 2010), and a decreased activity of the hepatic ketone synthesis pathway seen in streptozotocin-diabetic rats, with a decreased activity of the corresponding rate-limiting enzyme HMG-CoA (El Midaoui et al. 2006). Whereas streptozotocin diabetic rats showed a greatly increased activity of the branched-chain alpha-ketoacid dehydrogenase (BCKDH) complex, the rate-limiting enzyme in the catabolism of branched-chain amino acids, such activity was normalized by regular exercise (Li et al. 2001). Regular exercise also attenuated the reduction in hepatic IGF-1 seen in alloxan-diabetic rats (Leme et al. 2009).
Exercise training also reduced hepatic JNK and NF-κB, and lessened endoplasmic reticular stress as shown by decreasing phosphorylation of the two major metabolic markers of this condition (protein-kinase like endoplasmic reticular kinase, PERK and eukaryotic initiation factor 2, eIF2 phosphorylation) (da Luz et al. 2011). Moreover, the glucose stimulation of insulin secretion was decreased in rats that were given access to an exercise wheel, without any deterioration in glucose homeostasis; activity of the insulin-inducible enzyme hepatic glucose kinase (the first stage in glucose utilization) was decreased, possibly due to the lesser output of insulin (Zawalich et al. 1982). Seven days of voluntary wheel running increased the release of the hormone-like hepatic insulin sensitizing substance (HISS), thus decreasing the peripheral insulin resistance of rats (Chowdhury et al. 2013). Aging decreases the hepatic output of HISS, but again this could be countered by allowing the rat free access to a running wheel (Chowdhury et al. 2011). Exercise partially reversed attenuated insulin and leptin signalling in chlorpromazine-induced diabetes in rats by increasing concentrations of insulin-receptor substrate-2 protein (Park et al. 2007). In exercised mice, the enhanced insulin sensitivity was associated with an increased hepatic expression of endosomal adaptor protein APPL1, which blocks the association of protein kinase AKT with its endogenous inhibitor tribbles-related protein 3 (TRB3), and there was a decreased expression of TRB3 (Marinho et al. 2012).
In contrast, several metabolic precursors of steatosis were seen in hyperphagic obese rats following a sudden 1-week cessation of exercise. Changes included a decrease in hepatic mitochondrial oxidative capacity, an increased hepatic expression of lipogenetic proteins, and increased levels of hepatic malonyl CoA (Rector et al. 2008).
Additional effects of exercise training upon insulin sensitivity arise outside the liver, from an increase in muscle mass, an alteration in muscle quality, the greater energy demands of skeletal muscle, and the reduction of visceral fat stores (with a lesser incorporation of fatty acids into the liver). Exercise programmes may also influence hepatic function by modulating myostatin output. Myostatin inhibits muscle growth, thus predisposing to obesity, hepatic insulin resistance and diabetes; it may also have more direct effects upon hepatocytes (Allen et al. 2011). Inactivation of the myostatin gene in mice caused hepatic steatosis in the absence of any change in muscle mass (Mukherjee et al. 2007), and injection of recombinant myostatin slowed overall growth through a decrease in IGF-1 induced AKT phosphorylation, again without change of muscle mass (Hittel et al. 2010). Finally, both mouse and human liver cell cultures developed apoptosis when incubated with recombinant activin, which binds to the same receptors as myostatin (Woodruff et al. 1993; Chen et al. 2000).
Exercise dose recommendations in hepatic disease
From the investigations discussed above, we may conclude that regular aerobic exercise can reduce liver fat levels and this benefit can occur, albeit probably to a lesser extent, without weight loss. In humans, the majority of therapeutic programmes have prescribed exercise at moderate to vigorous intensities for 3–5 days per week (Table 7). However, clearer information is needed on the efficacy of resistance versus aerobic exercise, the minimum dose of physical activity required for benefit, the exercise tolerance of individuals with NAFLD, and doses of exercise that may lead to hepatic injury.
Whilst it appears that regular aerobic exercise of moderate or vigorous intensity is effective in decreasing hepatic fat content, vigorous exercise may not always be practical. Fatigue (probably centrally mediated) is a frequent concomitant of hepatic steatosis (Bergasa et al. 2004), and this may reduce a patient’s motivation, or even preclude participation in sustained aerobic activity, especially if this is vigorous. Moreover, co-morbid obesity can in itself reduce functional capacity and discourage involvement in exercise programmes, especially if vigorous activity is required. In this context, the only study to date that has examined predictors of physical activity adoption and adherence in a NAFLD cohort concluded that initial confidence in the ability to exercise was often low, in part because of a fear of falling (Frith et al. 2010). Whilst participation in a supervised exercise programme with individuals similar to oneself is well known to improve self-efficacy and reduce fears of falling, in patients where such an approach is found to be ineffective, more unconventional tactics may be needed to increase daily energy expenditures. One investigation demonstrated that a significant reduction of ALT could be achieved by regular voluntary and electrical stimulation of the quadriceps and hamstring muscles in individuals who were resistant to lifestyle intervention (Kawaguchi et al. 2011).
Conclusions
Like many body systems, the liver seems well adapted to meet the demands of regular moderate physical activity. However, function becomes impaired with prolonged periods of inadequate physical activity, and extremely prolonged vigorous exercise can also have adverse consequences, particularly under harsh environmental conditions.
Acute exercise stimulates hepatic glycogenolysis and gluconeogenesis, increases the synthesis of some proteins, and may cause oxidative stress. Enzymes involved in carbohydrate metabolism are up-regulated, and lipogenic enzymes are down-regulated. Humoral changes seem the primary triggers for these changes, but the possible roles of hepatic afferent nerves, cytokines, reactive oxygen species, and reduced hepatic blood flow remain to be clarified.
Regular moderate exercise appears to build upon the changes induced by a single session of vigorous physical activity, although further studies are needed in individuals who began training with a low hepatic fat content. In obese subjects, hepatic fat content is reduced, hypertrophy of hepatic tissue is stimulated, and clearance functions are enhanced by exercise training. Blood glucose homeostasis is also improved because of increased glycogen storage and an up-regulation of enzymes involved in carbohydrate metabolism. Fat storage is decreased by a down-regulation of lipogenic enzymes and increased lipid metabolism. Production of heat shock proteins is increased and the secretion of orixogenic proteins is decreased. Increases of antioxidant enzymes and stores of reduced glutathione enhance resistance to oxidant stress. Triggers of metabolic responses to chronic exercise seem modulations of insulin, insulin-like growth factor, glucagon and interleukin-6.
Inadequate physical activity predisposes to steatosis and associated disorders, including the metabolic syndrome, cardiovascular disease and diabetes mellitus. Simple steatosis can progress to hepatitis, cirrhosis and even hepatic carcinoma. Therapeutic exercise programmes restore insulin sensitivity, counteract diabetes and steatosis, and may facilitate recovery from hepatitis. However, the optimal exercise prescription remains to be defined in terms of efficacy and patient acceptance.
In summary, regular moderate physical activity makes an important contribution to the maintenance of optimal liver function, and this seems one more good reason to commend daily exercise as an important part of a healthy lifestyle.
Abbreviations
- ACC:
-
Acetyl-coa carboxylase
- ADP:
-
Adenosine diphosphate
- AKT:
-
Protein kinase B
- ALT:
-
Alanine transaminase
- AMP:
-
Adenosine monophosphate
- AMPK:
-
Adenosine monophosphate kinase
- ARFRP1:
-
ADP-ribosylation factor-related protein 1
- AST:
-
Aspartate transaminase
- ATP:
-
Adenosine triphosphate
- BCKDH:
-
Branched-chain alpha-ketoacid dehydrogenase
- cAMP:
-
Cyclic adenosine monophosphate
- CK:
-
Cytokeratin
- CoA:
-
Coenzyme A
- CT:
-
Computerized tomography
- DNA:
-
Desoxyribonucleic acid
- eIF2:
-
Eukaryotic initiation factor 2
- ERK:
-
Extracellular signal-regulated kinase
- FFA:
-
Free fatty acid
- GGT:
-
Gamma glutamyl transferase
- GLUT-2:
-
Glucose-transporter-2
- G protein:
-
Guanine-nucleotide binding protein
- GTP:
-
Guanosine triphosphate
- HAD:
-
Β-hydroxyacyl-dehydrogenase
- HDL-c:
-
High-density lipoprotein cholesterol
- HISS:
-
Hepatic insulin sensitizing substance
- HMG-CoA:
-
Hydroxymethylglutaryl-CoA
- HSP:
-
Heat shock protein
- IGF-1:
-
Insulin-like growth factor-1
- IGFBP:
-
Insulin-like growth factor binding protein
- IL:
-
Interleukin
- IMTG:
-
Intramyocellular triglyceride
- JAK:
-
Janus kinase
- JNK:
-
c-jun N-terminal kinase
- LDH:
-
Lactate dehydrogenase
- MAPK:
-
Mitogen-activated protein kinase
- MDA:
-
Malondialdehyde
- mRNA:
-
Messenger ribonucleic acid
- NAFLD:
-
Non-alcoholic fatty liver disease
- NF-κB:
-
Nuclear factor kappa-B
- NOx:
-
Mononitrogen oxides
- PECPK:
-
Phosphoenolpyruvate carboxykinase
- PERK:
-
Protein-kinase like endoplasmic reticular kinase
- SCD-1:
-
Stearoyl-CoA desaturase-1
- sFasL:
-
Soluble Fas ligand
- SREBP-1c:
-
Regulatory element-binding protein-1c
- STAT:
-
Signal transducer and activator of transcription
- TRB3:
-
Tribbles-related protein 3
- VLDL:
-
Very low density lipoprotein triglycerides
- \({\dot{\text{V}}}\)O2max :
-
Maximal oxygen intake
References
Ahlborg G, Felig P, Hagenfel L, Hendler R, Wahren J (1974) Substrate turnover during prolonged exercise in man. Splanchnic and leg metabolism of glucose, free fatty-acids, and amino-acids. J Clin Invest 53(4):1080–1090
Albu JB, Hellbronn LK, Kelley DE, Smith SR, Azuma K, Berk ES, Pi-Sunyer FX, Ravussin E, Look Ahead Research Group (2010) Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes. Diabetes 59:627–633
Alisi A, Locatelli M, Nobili V (2010) Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care 13(4):397–402
Allen DL, Hittel DS, McPherron AC (2011) Expression and function of myostatin in obesity, diabetes, and exercise adaptation. Med Sci Sports Exerc 43(10):1828–1835
Andersen H, Borre M, Jakobsen J, Andersen PH, Vilstrup H (1998) Decreased muscle strength in patients with alcoholic liver cirrhosis in relation to nutritional status, alcohol abstinence, liver function, and neuropathy. Hepatology 27(5):1200–1206
Angulo P (2002) Non-alcoholic fatty liver disease. New Engl J Med 346:1221–1231
Anthony TG, Anthony JC, Lewitt MS, Donovan SM, Layman DK (2001) Time course changes in IGFBP-1 after treadmill exercise and postexercise food intake in rats. Am J Physiol 280:E650–E656
Aoi W, Naito Y, Hang LP, Uchiyama K, Akagiri S, Mizushima K, Yoshikawa T (2011) Regular exercise prevents high-sucrose diet-induced fatty liver via improvement of hepatic lipid metabolism. Biochem Biophys Res Comm 413(2):330–335
Apple FS, McGue MK (1983) Serum enzyme changes during marathon training. Am J Clin Pathol 79(6):716–719
Arase Y, Suzuki F, Ikeda K, Kumada H, Tsuji H, Kobayashi T (2009) Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease. J Gastroenterol 44(10):1064–1070
Askew EW, Barakat H, Kuhl GL, Dohm GL (1975) Response of lipogenesis and fatty acid synthetase to physical training and exhaustive exercise in rats. Lipids Health Dis 10(8):491–496
Atalay M, Oksala NKJ, Laaksonen DE, Khanna S, Nakao C, Lappalainen J, Roy S, Hanninen O, Sen CK (2004) Exercise training modulates heat shock protein response in diabetic rats. J Appl Physiol 97:805–811
Aydin C, Ince E, Koiparan S, Cangul IT, Naziroglu M, Ak F (2005) Protective effects of long term dietary restriction on swimming exercise-induced oxidative stress in the liver, heart and kidney of rat. Cell Bioch Funct 25(2):129–137
Baba CS, Alexander G, Kalyani B, Pandey R, Rastogi S, Pandey A, Gourdas C (2006) Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. J Gastroenterol Hepatol 21(1 Pt 1):191–198
Bacchi N, Moghetti P (2013) Exercise for hepatic fat accumulation in type 2 diabetic subjects. Int J Endocrinol ID 309191:1–5
Bacchi E, Negri C, Targher G, Faccioli N, Lanza M, Zoppini G, Zanolin E, Schena F, Bonora E, Moghetti P (2013) Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 randomized trial). Hepatol 58(4):1287–1295
Bae JC, Suh S, Park SE, Rhee EJ, Park CY, Oh KW, Park SW, Kim SW, Hur KY, Kim JH, Lee M-S, Lee MK, Kim K-W, Lee W-Y (2012) Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adults. PLoS One 7(10):e46819
Balasubramian K, Mawer GE, Simons PJ (1970) The influence of dose on the distribution and elimination of amylobarbitone in healthy subjects. Br J Pharmacol 40(3):578–579
Baldwin KM, Reitman JS, Terjung RL, Winder WW, Holloszy JO (1973) Substrate depletion in different types of muscle and liver during prolonged running. Am J Physiol 225(5):1045–1050
Banzet S, Koulmann N, Simler N, Chapot R, Serrurier B, Peinnequin A, Bigard X (2009) Control of gluconeogenic genes during intense/prolonged exercise: hormone independent effect of muscle-derived IL-6 on hepatic tissue and PEPCk mRNA. J Appl Physiol 107(6):1830–1839
Barsalani R, Chapados NA, Lavoie J-M (2010) Hepatic VLDL-TG production and MTP gene expression are decreased in ovariectomized rats: effects of exercise training. Hormone Metabol Res 42(12):860–867
Barsalani R, Riesco E, Lavoie JM, Dionne IJ (2013) Effect of exercise training and isoflavones on hepatic steatosis in overweight postmenopausal women. Climacteric 16(1):88–95
Bay Nielsen H, Secher NH, Clemmesen O, Ott P (2005) Maintained cerebral and skeletal muscle oxygenation during maximal exercise in patients with liver cirrhosis. J Hepatol 43(2):266–271
Beard ME, Hamer JW, Hamilton G, Maslowski AH (1979) Jogger’s heat stroke. NZ Med J 89(631):159–161
Behrens G, Matthews CE, Moore SC, Freedman ND, McGlynn KA, Everhart JE, Hollenbeck AR, Leitzmann MF (2013) The association between frequency of vigorous physical activity and hepatobiliary cancers in the NIH-AARP diet and health study. Eur J Epidemiol 28(1):55–66
Bejma J, Ramires P, Ji LL (2000) Free radical generation and oxidative stress with ageing and exercise: differential effects in the myocardium and liver. Acta Physiol Scand 169(4):343–351
Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, Tiribelli C (2000) Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132(2):112–117
Berg A, Keul J (1982) Serum enzymkinetik während und nach intensiver Langzeitbelastung (Serum enzyme kinetics during and after endurance exercise). Dtsch Z fur Sportmed 33:12–17
Bergasa NV, Mehlman J, Bir K (2004) Aerobic exercise: a potential therapeutic intervention for patients with liver disease. Med Hypoth 62(6):935–941
Berglund ED, Lee-Young RS, Lustig DG, Lynes SE, Donahue EP, Camacho RC, Meredith ME, Magnuson MA, Charron MJ, Wasserman DH (2009) Hepatic energy state is regulated by glucagon receptor signaling in mice. J Clin Invest 119(8):2412–2422
Berglund ED, Lustig DG, Baheza RA, Hasenour CM, Lee-Young RS, Donahue EP, Lynes SE, Swift LL, Charron MJ, Damon BM, Wasserman DH (2011) Hepatic glucagon action is essential for exercise-induced reversal of mouse fatty liver. Diabetes 60(11):2720–2729
Bergstrom J, Hermansen L, Hultman E, Saltin B (1967) Diet, muscle glycogen and physical performance. Acta Physiol Scand 71(2):140–150
Bermon S, Ferrari P, Bernard P, Altare S, Dolisi C (1999) Responses of total and free insulin-like growth factor-I and insulin-like growth factor binding protein-3 after resistance exercise and training in elderly subjects. Acta Physiol Scand 165(1):51–56
Bexfield NA, Parcell AC, Nelson WB, Foote KM, Mack GW (2009) Adaptations to high-intensity intermittent exercise in rodents. J Appl Physiol 107(3):749–754
Boel J, Andersen LB, Hansen SH, Dossing M (1984) Hepatic drug metabolism and physical fitness. Clin Pharmacol Therap 36(1):121–126
Bonekamp S, Barone B, Clark JM, Stewarts KJ (2008) The effect of exercise training intervention on hepatic steatosis. Hepatol 48(S1):806A
Børsheim E, Knardahl DS, Høstmark AT (1999) Short-term effects of exercise on plasma very low density lipoproteins (VLDL) and fatty acids. Med Sci Sports Exerc 31(4):522–530
Botezelli JD, Mora RF, Dalia RA, Moura LP, Cambri LT, Ghezzi AC, Voltarelli FA, Mello MA (2010) Exercise counteracts fatty liver disease in rats fed on fructose- rich diet. Lipids Health Dis 9:116 (0n-line publication)
Bouchard C, Shephard RJ (1994) Physical activity, fitness and health: the model and key concepts. In: Bouchard C, Shephard RJ, Stephens T (eds) Physical activity, fitness and health. Human Kinetics, Champaign, pp 77–88
Bozzetto L, Prinster A, Annuzzi G, Costagilola L, Mangione A, Vitelli A, Mazzarella R, Longobardo M, Mancini M, Vigorito C, Riccardi G, Rivellese AA (2012) Liver fat is reduced by isoenergetic MUFA diet in a controlled random study in type 2 diabetic patients. Diabetes Care 35(7):1429–1435
Brinkley TE, Halverstadt A, Phares DA, Ferrell RE, Prigeon RL, Hagberg JM, Goldberg AP (2011) Hepatic lipase gene -514CT variant is associated with exercise training-induced changes in VLDL and HDL by lipoprotein. J Appl Physiol 111(6):1871–1876
Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatol 40(6):1387–1395
Bunch TW (1980) Blood test abnormalities in runners. Mayo Clin Proc 55(2):113–117
Bűrger-Mendonça M, Bielavsky M, Barbosa FCR (2008) Liver overload in Brazilian triathletes after half-ironman competition is related to muscle fatigue. Ann Hepatol 7(3):245–248
Burneiko RC, Diniz YS, Galhardi CM, Rodrigues HG, Ebaid GM, Faine LA, Padovani CR, Cicogna AC, Novelli EL (2006) Interaction of hypercaloric diet and physical exercise on lipid profile, oxidative stress and antioxidant defenses. Food Chem Toxicol 44(7):1167–1172
Busse M, Nordhusen D, Tegtbur U, Machold H, Panning B (2004) Sorbitol clearance during exercise as a measure of hepatic and renal blood flow. Clin Sportsmed Int 1:1–8
Caldwell S, Lazo M (2009) Is exercise an effective treatment for NASH? Knowns and unknowns. Ann Hepatol 8(Suppl 1):S60–S66
Cameron I, Alam MS, Wang J, Brown L (2012) Endurance exercise in a rat model of metabolic syndrome. Can J Physiol Pharmacol 90(11):1490–1497
Campillo B, Chapelain C, Bonnet JC, Frisdal E, Devanlay M, Bouissou P, Fouet P, Wirquin E, Atlan G (1990a) Hormonal and metabolic changes during exercise in cirrhotic patients. Metab Clin Exp 39(1):18–24
Campillo B, Fouet P, Bonnet JC, Atlan G (1990b) Submaximal oxygen consumption in liver cirrhosis. Evidence of severe functional aerobic impairment. J Hepatol 10(2):163–267
Centis E, Marzocchi R, Di Domizio S, Ciaravella MF, Marchesini G (2010) The effect of lifestyle changes in non-alcoholic fatty liver disease. Dig Dis 28(1):267–273
Cha Y-S, Kim H-Y, Daily J (2003) Exercise-trained but not untrained rats maintain free carnitine reserves during acute exercise. Asia Pac J Clin Nutr 12(1):120–126
Chang S-P, Chen Y-H, Chang W-C, Liu I-M, Cheng JT (2006) Merit of physical exercise to reverse the higher gene expression of hepatic phosphoenolpyruvate carboxykinase in obese Zucker rats. Life Sci 79(3):240–246
Chapados NA, Lavoie J-M (2010) Exercise training increases hepatic endoplasmic reticulum (er) stress protein expression in MTP-inhibited high-fat fed rats. Cell Biochem Funct 28(3):202–210
Chapados NA, Seelaender M, Levy E, Lavoie J-M (2009) Effects of exercise training on hepatic microsomal triglyceride transfer protein content in rats. Hormone Metabol Res 41(4):287–293
Charbonneau A, Couturier K, Gauthier M-S, Lavoie J-M (2005) Evidence of hepatic glucagon resistance associated with hepatic steatosis: reversal effect of training. Int J Sports Med 26(6):432–441
Chen W, Woodruff TK, Mayo KE (2000) Activin A-induced HepG2 liver cell apoptosis: involvement of activin receptors and smad proteins. Endocrinol 141(3):1263–1272
Chen YW, Nader GA, Baar KR, Federale MJ, Hoffman EP, Esser KA (2002) Response of rat muscle to acute resistance exercise defined by transcriptional and translational profiling. J Physiol 545(Pt 1):27–41
Chen S-M, Liu C-Y, Li S-R, Huang H-T, Tsai C-Y, Jou H-J (2008) Effects of therapeutic lifestyle program on ultrasound-diagnosed nonalcoholic fatty liver disease. J Chin Med Assoc 71(11):551–558
Cheung O, Sanyal AJ (2009) Recent advances in nonalcoholic fatty liver disease. Curr Opin Gastroenterol 25(3):230–237
Chowdhury KK, Legare DJ, Lautt WW (2011) Insulin sensitization by voluntary exercise in aging rats is mediated through hepatic insulin sensitizing substance (HISS). Exp Gerontol 46(1):73–80
Chowdhury KK, Legare DJ, Lautt WW (2013) Exercise enhancement of hepatic insulin- sensitising substance-mediated glucose uptake in diet-induced prediabetic rats. Br J Nutr 109(5):844–852
Christensen NJ, Galbo H (1983) Sympathetic nervous activity during exercise. Annu Rev Physiol 45:139–153
Church TS, Kuk JL, Ross R, Priest EL, Biltoff E, Blair DN (2006) Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. Gastroenterol 130(7):2023–2030
Cintra DE, Ropelle ER, Vitto MF, Luciano TF, Souza DR, Engelmann J, Marques SO, Lira FS, de Pinho RA, Pauli JR, De Souza CT (2012) Reversion of hepatic steatosis by exercise training in obese mice: the role of sterol regulatory element- binding protein-1c. Life Sci 91(11–12):395–401
Coggan AR, Swanson SC, Mendenhall LA, Habash DL, Kien CL (1995) Effect of endurance training on hepatic glycogenolysis and gluconeogenesis during prolonged exercise in men. Am J Physiol 268:E375–E383
Coker RH, Krishna MG, Lacy DB, Bracy DP, Wasserman DH (1997) Role of hepatic alpha- and beta-adrenergic receptor stimulation on hepatic glucose production during heavy exercise. Am J Physiol 273:E831–E838
Coker RH, Williams RH, Yeo SE, Kortebein PM, Bodenner DL, Kern PA, Evans WJ (2009) The impact of exercise training compared to caloric restriction on hepatic and peripheral insulin resistance in obesity. J Clin Endocrinol Metab 94(11):4258–4266
Colombo M, Gregersen S, Kruhoeffer M, Agger A, Xiao J, Jeppesen PB, Orntoft T, Ploug T, Galbo H, Hermansen K (2005) Prevention of hyperglycemia in Zucker diabetic fatty rats by exercise training: effects on gene expression in insulin- sensitive tissues determined by high-density oligonucleotide microarray analysis. Metabolism 54(12):1571–1581
Conjeevaram HS, Tiniakos DG (2011) Editorial: exercise for NAFLD: does intensity matter? Am J Gastroenterol 106(3):470–475
Corriveau P, Paquette A, Brochu M, Prud’homme D, Rabasa-Lhoret R, Lavoie JM (2008) Resistance training prevents liver fat accumulation in ovariectomized rats. Maturitas 59(3):259–267
Crevenna R, Schmidinger M, Keilani M, Nuhr M, Nur H, Zöch C, Zielinski C, Fialka-Moser V, Quittan M (2003) Aerobic exercise as additive palliative treatment for a patient with advanced hepatocellular cancer. Wien Med Wochenschr 153(9–10):237–240
Cullinane E, Siconolfi S, Saritelli A, Thompson PD (1982) Acute decrease in serum triglycerides with exercise—is there a threshold for an exercise effect. Metab Clin Exp 31(8):844–847
da Luz G, Frederico MJS, da Silva S, Vitto MF, Cesconetto PA, de Pinho RA, Pauli JR, Silva ASR, Cintra DE, Ropelle ER, De Souza CT (2011) Endurance exercise training ameliorates insulin resistance and reticulum stress in adipose and hepatic tissue in obese rats. Eur J Appl Physiol 111(9):2015–2023
da Silva LA, Pinho CA, Rocha LG, Tuon T, Silveira PC, Pinho RA (2009) Effect of different models of physical exercise on oxidative stress markers in mouse liver. Appl Physiol Nutr Metab 34(1):60–65
Daemen MJAP, Thijssen HHW, van Essen H, Vervoort-Peters HT, Prinzen FW, Struyker Boudier HA, Smits JF (1989) Liver blood flow measurement in the rat: the electromagnetic versus the microsphere and clearance methods. J Pharmacol Methods 21(4):287–297
Daggan RN, Zafeiridis A, Dipla K, Puglia CD, Gratz I, Catalano E, Kendrick ZV (2000) The effects of chronic exercise on anaethesia-induced hepatotoxicity. Med Sci Sports Exerc 32(12):2024–2028
Davies KJ, Quintanilha AT, Brooks GA, Packer L (1982) Free radicals and tissue damage produced by exercise. Biochem Biophys Res Comm 107(4):1198–1205
de Araújo CC, Silva JD, Samary CS, Guimarães IH, Marques PS, Oliveira GP, do Carmo LGRR, Goldenberg RC, Bakker-Abreu I, Diaz BL, Rocha NN, Capelozzi VL, Pelosi P, Rocco PRM (2012) Regular and moderate exercise before experimental sepsis reduces the risk of lung and distal organ injury. J Appl Physiol 112(7):1206–1214
De Paz JA, Villa JG, Lopez P, Gonzalez-Gallego J (1995) Effects of long-distance running on serum bilirubin. Med Sci Sports Exerc 27(12):1590–1594
de Piano A, de Mello M, Sanches PL, da Silva P, Campos R, Carnier J, Corgosinho F, Foschini D, Masquio D, Tock L, Oyama L, do Nascimento C, Tufik S, Dãmaso AR (2012) Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents. Eur J Gastroenterol Hepatol 24(11):1313–1324
DeLissio M, Goodyear LJ, Fuller S, Krawitt EL, Devlin JT (1991) Effects of treadmill exercise on fuel metabolism in hepatic cirrhosis. J Appl Physiol 70(1):210–216
Della Corte C, Alisi A, Iorio R, Alterio A, Nobili V (2011) Expert opinion on current therapies for nonalcoholic fatty liver disease. Expert Opin Pharmacother 12(12):1901–1911
Devries MC, Samjoo IA, Hamadeh MJ, Tarnopolsky MA (2008) Effect of endurance exercise on hepatic lipid content, enzymes, and adiposity in men and women. Obesity (Silver Spring) 16(10):2281–2288
Dharancy S, Lemyze M, Boleslawski E, Neviere R, Declerck N, Canva V, Wallaert B, Mathurin P, Pruvot FR (2008) Impact of impaired aerobic capacity on liver transplant candidates. Transplantation 86(8):1077–1083
Dohm GL, Kasperek GJ, Barakat HA (1985) Time course of changes in gluconeogenic enzyme activities during exercise and recovery. Am J Physiol 249(1 Pt 1):E6–E11
Domingos MM, Rodrigues MFC, Stotzer US, Bertucci DR, Souza MKC, Marine DA, Gatto CV, de Araujo HSS, De Andrade Perez SE (2012) Resistance training restores the gene expression of molecules related to fat oxidation and lipogenesis in the liver of ovariectomized rats. Eur J Appl Physiol 112(4):1437–1444
Donovan CM, Pagliassotti MJ (1990) Enhanced efficiency of lactate removal after endurance training. J Appl Physiol 68(3):1053–1058
Donovan CM, Sumida KD (1990) Training improves glucose homeostasis in rats during exercise via glucose production. Am J Physiol 258(3 Pt 2):R770–R778
Døssing M (1985) Effect of acute and chronic exercise on hepatic drug metabolism. Clin Pharmacokinet 10(5):426–431
Dowman JK, Armstrong MJ, Tomlinson JW, Newsome PN (2011) Current therapeutic strategies in non-alcoholic fatty liver disease. Diabetes Obes Metab 13(8):692–702
Dressendorfer RH, Wade CE, Hornick C, Timmis GC (1982) High-density lipoprotein- cholesterol in marathon runners during a 20-day road race. JAMA 247(12):1715–1717
Drouin R, Robert G, Milot M, Massicotte D, Peronnet F, Lavoie C (2004) Swim training increases glucose output from liver perfused in situ with glucagon in fed and fasted rats. Metab Clin Exp 53(8):1027–1031
Ducry JJ, Howald H, Zysset T, Bircher J (1979) Liver function in physically trained subjects. Galactose elimination capacity, plasma disappearance of ICG, and aminopyrine metabolism in long distance runners. Dig Dis Sci 24(3):192–196
Duvnjak M, Tomasic V, Gomercic M, Smircic Duvnjak L, Barsic N, Lerotic I (2009) Therapy of nonalcoholic fatty liver disease: current status. J Physiol Pharmacol 60(Suppl 7):57–66
Dyke TM, Sams RA, Hinchcliff KW (1998) Intensity-dependent effects of acute submaximal exercise on the pharmacokinetics of bromsulphalein in horses. Am J Vet Res 59(11):1481–1487
Eckard C, Cole R, Lockwood J, Torres DM, Williams CD, Shaw JC, Harrison SA (2013) Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial. Ther Adv Gastroenterol 6(4):249–259
Eklöw L, Moldéus P, Orrenius S (1984) Oxidation of glutathione during hydroperoxide metabolism: a study using isolated hepatocytes and the glutathione inhibitor 1,3- bis(2 chloroethyl)-1-nitrosourea. Eur J Biochem 138(3):459–463
El Midaoui A, Chiasson JL, Tancrede G, Nadeau A (2006) Physical training reverses the increased activity of the hepatic ketone body synthesis pathway in chronically diabetic rats. Am J Physiol 290(2):E207–E212
Eran H, Ben-Ari Z, Heled Y, Moran DS, Shani Y, Epstein Y (2004) Liver transplantation in exertional heat stroke: a medical dilemma. Intensive Care Med 30(7):1474–1478
Eslami L, Merat S, Nasseri-Moghaddam S (2009) Treatment of non-alcoholic fatty liver disease (NAF LD): a systematic review. Middle East J Dig Dis 1(2):89–99
Fabbri A, Bianchi G, Zoli M, Marchi E, Marchesini G (1991) Effect of physical exercise on one-sample antipyrine clearance. Ital J Gastoenterol 23(2):74–76
Fallon KE, Sivyer G, Sivyer K, Dare A (1999) The biochemistry of runners in a 1600 km ultramarathon. Br J Sports Med 33:264–269
Fealy CE, Haus JM, Solomon TP, Pagadala M, Flask CA, McCullough AJ, Kirwan JP (2012) Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease. J Appl Physiol 113(1):1–6
Febbraio MA, Ott P, Nielsen HB, Steensberg A, Keller C, Krustrup P, Secher NH, Pedersen BK (2002) Exercise induces hepatosplanchnic release of heat shockprotein 72 in humans. J Physiol 544(Pt 3):957–962
Febbraio MA, Ott P, Nielsen HB, Steensberg A, Keller C, Krustrup P, Secher NH, Pedersen BK (2003) Hepatosplanchnic clearance of interleukin-6 in humans during exercise. Am J Physiol 285(2):E397–E402
Felig P, Wahren J (1971) Amino acid metabolism in exercising man. J Clin Invest 50(12):2703–2712
Fiebig R, Griffiths MA, Gore MT, Baker DH, Oscai L, Ney DM, Ji LL (1998) Exercise training down-regulates hepatic lipogenic enzymes in meal-fed rats: fructose versus complex-carbohydrate diets. J Nutr 128(5):810–817
Fiebig RG, Hollander JM, Ji LL (2001) Exercise down-regulates hepatic fatty acid synthase in stretozotocin-treated rats. J Nutr 131(9):2252–2259
Fiebig RG, Hollander JM, Ney D, Boileau R, Jeffery E, Ji LL (2002) Training down-regulates fatty acid synthase and body fat in obese Zucker rats. Med Sci Sports Exerc 34(7):1106–1114
Fintini D, Pietrobattista A, Morino G, Cafiero G, Calzolari A, Turchetta A, Brufani C, Alisi A, Giordano U, Nobili V (2012) Energy expenditure and insulin sensitivity evaluation in obese children affected by hepatosteatosis. Pediatr Obesity 7(2):e4–e7
Finucane FM, Sharp SJ, Purslow LR, Horton K, Horton J, Savage DB, Brage S, Besson H, De Lucia Rolfe E, Sleigh A, Martin HJ, Aihie Sayer A, Cooper C, Ekelund U, Griffin SJ, Wareham NJ (2010) The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire cohort study: a randomised controlled trial. Diabetalogia 53(4):624–631
Flamm SD, Taki J, Moore R, Lewis SF, Keech F, Masltais F, Ahmad M, Callahan R, Dragotakes S, Alpert N, Strauss HW (1990) Redistribution of regional and organ blood volume and effect on cardiac function in relation to upright exercise intensity in healthy human subjects. Circulation 81(5):1550–1559
Foigt E, Ekelund L-G, Hultman E (1976) Enzyme activities in hepatic venous blood under strenuous physical exercise. Pflügers Arch 361(3):287–296
Frank S, Somani SM, Konle M (1990) Effect of exercise on propranolol pharmacokinetics. Eur J Clin Pharmacol 39:391–394
Franzese A, Vajro P, Arngeniziano A, Puzzielo A, Iannucci MP, Saviano MC, Brunetti F, Rubino A (1997) Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 42(7):1428–1432
Frenkl R, Gyore A, Szeberenyi S (1980) The effect of muscular exercise on the microsomal enzyme system of the rat liver. Eur J Appl Physiol 44(2):135–140
Friedman JE (1994) Role of glucocorticoids in activation of hepatic PEPCK gene transcription during exercise. Am J Physiol 266(4 Pt 1):E560–E566
Frith J, Day CP, Robinson L, Elliott C, Jones DEJ, Newton JL (2010) Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease. J Hepatol 52(1):112–116
Fritsche L, Weigert C, Haring HU, Lehrmann R (2008) How insulin receptor substrate proteins regulate the metabolic capacity of the liver-implications for health and disease. Curr Med Chem 15(13):1316–1329
Fritsche L, Hoene M, Lehmann R, Ellingsgaard H, Hennige AM, Pohl AK, Häring HU, Schleicher ED, Weigert C (2010) IL-6 deficiency in mice neither impairs induction of metabolic genes in the liver nor affects blood glucose levels during fasting and moderately intense exercise. Diabetologia 53(8):1732–1744
Froelich JE, Strauss HW, Moore RH, McKusick KA (1988) Redistribution of visceral blood volume in upright exercise in healthy volunteers. J Nucl Med 29(10):1714–1718
Fuwii M, Isikawa M, Iuchi M, Tashiro S (2005) Effect of follistatin on liver regeneration and tumor growth after portal occlusion. Hepatogastroenterol 52(63):833–838
Garcia-Pagan JC, Santos C, Barbera JA, Luca A, Roca J, Rodriguez-Roisin R, Bosch J, Rodes J (1996) Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterol 111(5):1300–1306
Gauthier M-S, Couturier K, Latour J-G, Lavoie J-M (2003) Concurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis. J Appl Physiol 94(6):2127–2134
Gauthier M-S, Couturier K, Charbonneau A, Lavoie J-M (2004) Effects of introducing physical training in the course of a 16-week high-fat diet regimen on hepatic steatosis, adipose tissue fat accumulation, and plasma lipid profile. Int J Obes Relat Metab Disord 28(8):1064–1071
Gerber L, Otgonsuren M, Mishra A, Escheik C, Birerdinc A, Stepanova M, Younossi ZM (2012) Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study. Aliment Pharmacol Therap 36(8):772–781
Ghanbari-Niaki A, Khabazian BM, Hossaini-Kakhak SA, Rahbarizadeh F, Hedayati M (2007) Treadmill exercise enhances ABCA1 expression in rat liver. Biochem Biophys Res Comm 361(4):841–846
Ghanbari-Niaki A, Fathi R, Kakhak SAH, Farshidi Z, Barmaki S, Rahbarizadeh F, Kraemer RR (2009) Treadmill exercise’s reduction of Agouti-related protein expression in rat liver. Int J Sport Nutr Ex Metab 19(5):473–484
Giercksky T, Boberg KM, Farstad IN, Halvorsen S, Schrumpf E (1999) Severe liver failure in exertional heat stroke. Scand J Gastroenterol 34(8):8245–8827
Godin DV, Garnett ME (1992) Species related variations in anti-oxidant status- II. Differences in susceptibility to oxidative challenge. Comp Biochem Physiol 103(3):743–748
Gonzalez B, Manso R (2004) Induction, modification and accumulation of HSP70s in the rat liver after acute exercise: early and late responses. J Physiol 556(Pt 2):369–385
Goodpaster BH, Delany JP, Otto AD, Kuller L, Vockley J, South-Paul JE, Thomas SB, Brown J, McTigue K, Hames KC, Lang W, Jakicic JM (2010) Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA 304(16):1795–1802
Gore M, Fiebig R, Hollander J, Leeuwenburgh C, Ohno H, Ji LL (1998) Endurance training alters antioxidant enzyme gene expression in rat skeletal muscle. Can J Physiol Pharmacol 76(12):1139–1145
Gorski J, Oscai LB, Palmer WK (1990) Hepatic lipid metabolism in exercise and training. Med Sci Sports Exerc 22(2):213–221
Griffiths MA, Fiebig RG, Gore MT, Baker DH, Esser K, Oscai L, Ji LL (1996) Exercise down-regulates hepatic lipogenic enzymes in food-deprived and refed rats. J Nutr 126(8):1959–1971
Grønbæk H, Lange A, Birkebæk NH, Holland-Fischer P, Solvig J, HØrlyck A, Kristensen K, Rittig S, Vilstrup H (2012) Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children. J Pediatr Gastroenterol Nutr 54(2):223–228
Gündüz F, Sentürk UK, Kuru O, Aktekin B, Aktekin MR (2004) The effect of one year’s swimming exercise on oxidant and antoxidant capacity in aged rats. Physiol Res 53(2):171–176
Haase TN, Ringholm S, Leick L, Bienso RS, Kiilerich K, Johansen S, Nielsen MM, Wojtaszewski JF, Hidalgo J, Pedersen PA, Pilegaard H (2011) Role of PGC-1 in exercise and fasting-induced adaptations in mouse liver. Am J Physiol 301(5):R1501–R1509
Hallsworth K, Fattakhova G, Hollingsworth K, Thoma C, Moore S, Taylor R, Day C, Trenell M (2011) Resistance exercise reduces liver fat and its mediators in non- alcoholic fatty liver disease independent of weight loss. Gut 60(9):1278–1283
Halverstadt A, Phares DA, Wilund KR, Goldberg AP, Hagberg JM (2007) Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women. Metab Clin Exp 56(4):444–450
Hammouda O, Chtouru H, Chaouchi A, Chahed H, Ferchichi S, Kallel C, Chamari K, Souissi N (2012) Effect of short-term maximal exercise on biochemical markers of muscle damage, total antioxidant status and homocysteine levels in football players. Asian J Sports Med 3(4):239–246
Hannukainen JC, Nuutila P, Borra R, Kaprio J, Kujala UM, Janatuinen T, Heinonen OJ, Kapanen J, Viljanen T, Haaparanta M, Ronnemaa T, Parkkola R, Knuuti J, Kalliokoski KK (2007) Increased physical activity decreases hepatic free fatty acid uptake: a study in human monozygotic twins. J Physiol 578(Pt 1):347–358
Hansen J, Brandt C, Nielsen AR, Hojman P, Whitham M, Febbraio MA, Pedersen BK, Plomgaard P (2011) Exercise induces a marked increase in plasma follistatin: evidence that follistatin is a contraction-induced hepatokine. Endocrinol 152(1):164–171
Hao L, Wang Y, Duan Y, Bu S (2010) Effects of treadmill exercise training on liver fat accumulation and estrogen receptor alpha expression in intact and ovariectomized rats with or without estrogen replacement treatment. Eur J Appl Physiol 109(5):879–886
Haram PM, Kemi OJ, Lee SJ, Bendheim MO, Al-Share QY, Waldum HL, Gilligan LJ, Koch LG, Britton SL, Najjar SM, Wisloff U (2009) Aerobic interval training vs. continuous moderate exercise in the metabolic syndrome of rats artificially selected for low aerobic capacity. Cardiovasc Res 81(4):723–732
Hassanein T, Razack A, Gavaler JS, Van Thiel DH (1992) Heatstroke: its clinical and pathological presentation, with particular attention to the liver. Am J Gastroenterol 87(10):1382–1389
Hattar LN, Wilson TA, Tabotabo LA, Smith OB, Abrams SH (2011) Physical activity and nutrition attitudes in obese Hispanic children with non-alcoholic steatohepatitis. World J Gastroenterol 17(39):4396–4403
Haufe S, Engeli S, Budziarek P, Utz W, Schulz-Menger J, Hermsdorf M, Wiesner S, Otto C, Haas V, de Greiff A, Luft FC, Boschmann M, Jordan J (2010) Cardiorespiratory fitness and insulin sensitivity in overweight or obese subjects may be linked through intrahepatic lipid content. Diabetes 59(7):1640–1647
Havel RJ, Kane JP, Balasse EO, Segel N, Basso LV (1970) Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J Clin Invest 49(11):2017–2035
He Y, Zhang H, Fu F (2008) The effects of swimming exercise on high-fat-diet-induced steatohepatitis. J Sports Med Phys Fitness 48(2):259–265
Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F (2003) Principles of interleukin (IL)-6 type cytokine signalling and its regulation. Biochem J 374(Pt 1):1–20
Helge JW, Watt PW, Richter EA, Rennie MJ, Kiens B (2001) Fat utilization during exercise: adaptation to a fat-rich diet increases utilization of plasma fatty acids and very low density lipoprotein-triacylglycerol in humans. J Physiol 537(Pt 3):1009–1020
Hickman IJ, Jonsson JR, Prins JB, Ash S, Purdie DM, Clouston AD, Powell EE (2004) Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 53(3):413–419
Hittel DS, Axelson M, Sarna N, Shearer J, Huffman KM, Kraus WE (2010) Myostatin decreases with aerobic exercise and associates with insulin resistance. Med Sci Sports Exerc 42(11):2023–2029
Ho KP, Xiao DS, Ke Y, Oian ZM (2001) Exercise decreases cytosolic aconitase activity in the liver, spleen and bone marrow in rats. Biochem Biophys Res Comm 282(1):264–267
Hoene M, Weigert C (2010) The stress response of the liver to physical exercise. Ex Immunol Rev 16:163–183
Hoene M, Lehmann R, Hennige AM, Pohl AK, Häring HU, Schleicher ED, Weigert C (2009) Acute regulation of metabolic genes and insulin receptor substrates in the liver of mice by one single bout of treadmill exercise. J Physiol 587(Pt 1):241–252
Hoene M, Franken H, Fritsche L, Lehmann R, Pohl AK, Häring H-U, Zell A, Schelischer ED, Weigert C (2010) Activation of the mitogen-activated protein kinase (MAPK) signalling pathway in the liver of mice is related to plasma glucose levels after acute exercise. Diabetalogia 53(6):1131–1141
Holly RG, Barnard RJ, Rosenthal M, Applegate E, Pritikin N (1986) Triathlete characterization and response to prolonged strenuous competition. Med Sci Sports Exerc 18(1):123–127
Holt HN, Wild SH, Wareham N, Ekelund U, Umpleby M, Shojaee-Moradie F, Holt RIG, Phillips DI, Byrne CD (2007) Differential effects of fatness, fitness and physical activity energy expenditure on whole-body, liver and fat insulin sensitivity. Diabetologia 50(8):1698–1706
Hong H, Johnson P (1995) Antioxidant enzyme activities and lipid peroxidation levels in exercised and hypertensive rat tissues. Int J Biochem Cell Biol 27(9):923–931
Hsieh SD, Yoshinaga H, Muto T, Sakurai Y (1998) Regular physical activity and coronary risk factors in Japanese men. Circulation 97(7):661–665
Hu Y, Gursoy E, Cardounel A, Kalimi M (2000) Biological effects of single and repeated swimming stress in male rats: beneficial effects of glucocorticoids. Endocrine 13(1):123–129
Hu C, Hoene M, Zhao X, Häring HU, Schleicher E, Lehmann R, Han X, Xu G, Weigert C (2010) Lipidomics analysis reveals efficient storage of hepatic triacylglycerides enriched in unsaturated fatty acids after one bout of exercise in mice. PLoS One 5(10):e13318
Huang H, Iida KT, Sone H, Ajisaka R (2007) The regulation of adiponectin receptor expression by acute exercise in mice. Exp Clin Endocrinol Diabetes 115(7):417–422
Huang C-C, Tsai S-C, Lin W-T (2008) Potential ergogenic effects of l-arginine against oxidative and inflammatory stress induced by acute exercise in aging rats. Exp Gerontol 43(6):571–577
Huang C-C, Lin W-T, Hsu F-L, Tsai PW, Hou CC (2010) Metabolomics investigation of exercise-modulated changes in metabolism in rat liver after exhaustive exercise. Eur J Appl Physiol 108(3):557–566
Huang CC, Yang S-C, Chan C-C, Lin W-T (2013) Ganoderma tsugae hepatoprotection against exhaustive exercise-induced liver injury in rats. Molecules 18(2):1741–1754
Hurren NM, Balanos GM, Blannin AK (2011) Is the beneficial effect of prior exercise on postprandial lipaemia partly due to redistribution of blood flow? Clin Sci 120(12):537–548
Jackson KC, Wohlers LM, Valencia AP, Cilenti M, Borengasser SJ, Thyfault JP, Spangenburg EE (2011) Wheel running prevents the accumulation of monounsaturated fatty acids in the liver of ovariectomized mice by attenuating changes in SCD-1 content. Appl Physiol Nutr Metab 36(6):798–810
Jakovljevic D, Hallsworth K, Zalewski P, Thoma C, Klawe J, Day C, Newton J, Trenell M (2013) Resistance exercise improves autonomic regulation at rest and haemodynamic response to exercise in non-alcoholic fatty liver disease. Clin Sci 125(3):143–149
James DE, Kraegen EW (1984) The effect of exercise training on glycogen, glycogen synthase and phosphorylase in muscle and liver. Eur J Appl Physiol 52(3):276–281
Jenkins NT, Hagberg JM (2011) Aerobic training effects on glucose tolerance in prediabetic and normoglycemic humans. Med Sci Sports Exerc 43(12):2231–2240
Jensen MD (1995) Gender differences in regional fatty-acid metabolism before and after meal ingestion. J Clin Invest 96(5):2297–2303
Ji LL, Dillon D, Wu E (1990) Alteration of antioxidant enzymes with aging in skeletal muscle and liver. Am J Physiol 258(4 Pt 2):R918–R923
Jiang Y, Cyress AM, Muse ED, Wu CR, Unson CG, Merrifield RB, Sakmar TP (2001) Glucagon receptor activates extracellular signal-reghulated protein kinase 1/2 via cAMP-dependent protein kinase. Proc Natl Acad Sci USA 98(18):10102–10107
Jin YJ, Kim KM, Hwang S, Lee SG, Ha TY, Song GW, Jung DH, Kim KH, Yu E, Shim JH, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ (2012) Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors. J Gastroenterol Hepatol 27(8):1341–1347
Johnson NA, George J (2010) Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease. Hepatol 52(1):370–381
Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A, Thompson MW, George J (2009) Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatol 50(4):1105–1112
Johnson NA, van Overbeek D, Chapman PG, Thompson MW, Sachinwalla T, George J (2012) Effect of prolonged exercise and pre-exercise dietary manipulation on hepatic triglycerides in trained men. Eur J Appl Physiol 112(5):1817–1825
Jones JC, Coombes JS, Macdonald GA (2012) Exercise capacity and muscle strength in patients with cirrhosis. Liver Transpl 18(2):146–151
Kang JH, Greenson JK, Omo JT, Chao C, Peterman D, Anderson L, Foess-Wood L, Sherbondy MA, Conjeevaram HS (2006) Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD. Am J Gastroenterol 101(10):2247–2253
Kantartzis K, Thamer C, Peter A, Machann J, Schick F, Schraml C, Konigsrainer A, Konigsrainer I, Krober S, Niess A, Fritsche A, Haring H-U, Stefan N (2009) High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Gut 58(9):1281–1288
Katsanos CS (2004) Lipid-induced insulin resistance in the liver: role of exercise. Sports Med 34(14):955–965
Katz M, Bergman EN (1969) Simultaneous measurements of hepatic and portal venous blood flow in the sheep and dog. Am J Physiol 216(4):946–952
Kawaguchi T, Shiba N, Maeda T, Matsugaki T, Takano Y, Itou M, Sakata M, Taniguchi E, Nagata K, Sata M (2011) Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD: a pilot study. J Gastroenterol 46(6):746–757
Kawanishi N, Yano H, Mizokami T, Takahashi M, Oyanagi E, Suzuki K (2012) Exercise training attenuates hepatic inflammation, fibrosis and macrophage infiltration during diet induced-obesity in mice. Brain Behav Immun 26(6):931–941
Kayashima S, Ohno H, Fujioka T, Taniguchi N, Nagata N (1995) Leucocytosis as a marker of organ damage induced by chronic strenuous physical exercise. Eur J Appl Physiol 70(5):413–420
Kayatekin BM, Gonenc S, Acikgoz O, Uysal N, Dayi A (2002) Effects of sprint exercise on oxidative stress in skeletal muscle and liver. Eur J Appl Physiol 87(2):141–144
Keating SE, Hackett DA, George J, Johnson NA (2012) Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 57(1):157–166
Kelley GA, Kelley KS, Tran ZV (2005) Aerobic exercise, lipids and lipoproteins in overweight and obese adults: a meta-analysis of randomized controlled trials. Int J Obesity 29(8):881–893
Kelley GA, Kelley KS, Franklin B (2006) Aerobic exercise and lipids and lipoproteins in patients with cardiovascular disease: a meta-analysis of randomized controlled trials. J Cardiopulm Rehabil 26(3):131–139
Kelly M, Keller C, Avilucea PR, Keller P, Luo Z, Xiang X, Giralt M, Hidalgo J, Saha AK, Pedersen BK, Ruderman NB (2004) AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. Biochem Biophys Res Comm 320(2):449–454
Kemme MJ, Burggraaf J, Schoemaker RC, Paulson S, Karim A, Lentjes EG, Childs A, Braekman RA, Cohen AF (2000) The influence of reduced liver blood flow on the pharmacokinetics and pharmacodynamics of recombinant tissue factor pathway inhibitor. Clin Pharmacol Ther 67(5):504–511
Khanna S, Atalay M, Lodge JK, Laaksonen DE, Roy S, Hanninen O, Packer L, Sen CK (1998) Skeletal muscle and liver lipoyllysine content in response to exercise, training and dietary alpha-lipoic acid supplementation. Biochem Mol Biol Intern 46(2):297–306
Khazaeinia T, Ramsey AA, Tam YK (2000) The effects of exercise on the pharmacokinetics of drugs. J Pharm Pharm Sci 3(3):292–302
Kiens B (1993) Skeletal muscle substrate utilization during submaximal exercise in man: effect of endurance training. J Physiol 469:459–478
Kindermann W, Salas-Fraire, Sroka G, Miller U (1983) Serum enzymverhalten nach korperlicher Belastung—Abgrenzung von krankheitsbedingten Veranderungen (serum enzyme content after physical activity- demarcation of disease-related changes). Herz 3:117–123
Kiraly MA, Campbell J, Park EB, Bates HE, Yue JTY, Rao VM, Matthews SG, Bikopoulos G, Rozakis-Adcock M, Giacca A, Vranic M, Riddell MC (2010) Exercise maintains euglycemia in association with decreased activation of c-Jun NH2-terminal kinase and serine phosphorylation of IRS-1 in the liver of ZDF rats. Am J Physiol 298(3):E671–E682
Kistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF (2011) Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic f atty liver disease. Am J Gastroenterol 106(3):470–475
Kjaer M (1998) Hepatic glucose production during exercise. Adv Exp Med Biol 441:117–127
Kjaer M, Engfred K, Fernandes A, Secher NH, Galbo H (1993) Regulation of hepatic glucose production during exercise in humans: role of sympathoadrenergic activity. Am J Physiol 265(2 Pt 1):E275–E283
Klein S, Peters EJ, Holland OB, Wolfe RR (1989) Effect of short-term and long-term beta-adrenergic-blockade on lipolysis during fasting in humans. Am J Phsiol 257(1):E65–E73
Klotz U, Lűcke C (1978) Physical exercise and disposition of diazepam. Br J Clin Pharmacol 5(4):349–350
Koot BGP, van der Baan-Slootweg OH, Tamminga-Smeulders CLJ, Rijcken THP, Pels TH, Korevaar JC, van Aalderen WM, Jansen PLM, Benninga MA (2011) Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement. Arch Dis Child 96(7):669–674
Korenblat KM, Fabbrini E, Mohammed BS, Klein S (2008) Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterol 134(5):1369–1375
Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H (2008) Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterol 135(1):122–130
Koutedakis Y, Raafat A, Sharp NC, Rosmarin MN, Beard MJ, Robbins SW (1993) Serum enzyme activities in individuals with different levels of physical fitness. J Sports Med Phys Fitness 33(3):252–257
Koyama K, Kaya M, Ishigaki T, Tsujita J, Hori S, Seino T, Kasugai A (1999) Role of xanthine oxidase in delayed lipid peroxidation in rat liver induced by acute exhausting exercise. Eur J Appl Physiol 80(1):28–33
Krasnoff JB, Painter PL, Wallace JP, Bass NM, Merriman RB (2008) Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease. Hepatol 47(4):1158–1166
Kratz A, Lewandrowski KB, Siegel AJ, Chun KY, Flood JG, Van Cott EM, Lee-Lewandrowski E (2002) Effect of marathon running on hematologic and biochemical laboratory parameters, including cardiac markers. Am J Clin Pathol 118(6):856–863
Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, Bales CW, Henes S, Samsa GP, Otvos JD, Kulkarni KR, Slentz CA (2002) Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 347(19):1483–1492
Kregel KC, Moseley PL (1996) Differential effects of exercise and heat stress on liver HSP70 accumulation with aging. J Appl Physiol 80(2):547–551
Kugelmas M, Hill DB, Vivian B, Marsano L, McCalin CJ (2003) Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatol 38(2):413–419
Kuk JL, Nichaman MZ, Church TS, Blair DN, Ross R (2004) Liver fat is not a marker of metabolic risk in lean premenopausal women. Metabolism 53(8):1066–1071
Larson-Meyer DE, Newcomer BR, Heilbrunn LK, Volaufova J, Smith SR, Alfonso AJ, Lefevre M, Rood JC, Williamson DA, Ravussin E, Pennington CALERIE Team (2008) Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring) 16(6):1355–1362
Latour MG, Brault A, Huet PM, Lavoie JM (1999) Effects of acute physical exercise on hepatocyte volume and fuction in rat. Am J Physiol 276(5 Pt 2):R1258–R1264
Lavoie JM (2002) The contribution of afferent signals from the liver to metabolic regulation during exercise. Can J Physiol Pharmacol 80(11):1035–1044
Lavoie JM, Gauthier MS (2006) Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise. Cell Mol Life Sci 63(12):1393–1409
Lavoie JM, Fillon Y, Couturier K, Corriveau P (2002) Evidence that the decrease in liver glycogen is associated with the exercise-induced decrease increase in IGFBP-1. J Appl Physiol 93(2):798–804
Lawlor DA, Sattar N, Smith GD, Ebrahim S (2005) The associations of physical activity and adiposity with alanine aminotransferase and gamma glutamyltransferase. Am J Epidemiol 161(11):1081–1088
Lazo M, Solga SF, Horska A, Bonekamp S, Diehl AM, Brancati FL, Clark JM, Look Ahead Research Group (2008) The effect of one year of intensive lifestyle intervention on hepatic steatosis. Hepatol 48:813A
Lee KY, Kim SJ, Cha YS, So JR, Park JS, Kang KS, Chon TW (2006) Effect of exercise on hepatic gene expression in an obese mouse model using cDNA microarrays. Obesity (Silver Spring) 14(8):1294–1302
Lee YS, Kek BLK, Poh LKS, Saw SM, Loke KY (2008) Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children. J Pediatr Gastroenterol Nutr 47(2):172–178
Lee S, Bacha F, Hannon T, Kuk JL, Boesch C, Arslanian S (2012) Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. Diabetes 61(11):2787–2795
Légaré A, Drouin R, Milot M, Massicotte D, Peronnet F, Massicotte G, Lavoie C (2001) Increased density of glucagon receptors in liver from endurance-trained rats. Am J Physiol 280(1):E193–E196
Leite RD, Prestes J, Bernardes CF, Shiguemoto GE, Pereira GB, Duarte JO, Domingos MM, Baldissera V, de Perez ASE (2009) Effects of ovariectomy and resistance training on lipid content in skeletal muscle, liver, and heart; fat depots; and lipid profile. App Physiol Nutr Metab 34(6):1079–1086
Leme JACA, Silveira RF, Gomes RJ, Moura RF, Sibuya CA, Mello MAR, Luciano E (2009) Long-term physical training increases liver IGF-I in diabetic rats. Growth Horm Igf Res 19(3):262–266
Lemon PW, Nagle FJ (1981) Effect of exercise on protein and amino acid metabolism. Med Sci Sports Exerc 13(3):141–149
Leskinen T, Sipilä S, Alen M, Cheng S, Pietiläinen KH, Usenius JP, Suominen H, Kovanen V, Kainukainen H, Kaprio J, Kujala UM (2009) Leisure-time physical activity and high-risk fat: a longitudinal population-based twin study. Int J Obes (Lond) 33(11):1211–1218
Leu JI, George DL (2007) Hepatic IGFBP-1 is a prosurvival factor that binds BAK, protects the liver from apoptosis, and antagonizes the proapoptotic actions of p53 at mitochondria. Genes Dev 21(23):3095–3109
Levinger I, Goodman C, Peake J, Garnham A, Hare DL, Jerums G, Selig S (2009) Inflammation, hepatic enzymes and resistance training in individuals with metabolic risk factors. Diabetes Med 26(3):220–227
Li Z, Murakami T, Nakai N, Nagasaki M, Obayashi M, Xu M, Sato J, Oshida Y, Sato Y, Shimomura Y (2001) Modification by exercise training of activity and enzyme expression of hepatic branched-chain alpha-ketoacid dehydrogenase complex in streptozotocin-induced diabetic rats. J Nutr Sci Vitamniol (Tokyo) 47(5):345–350
Linden MA, Meers GM, Ruebl ML, Jenkins NT, Booth FW, Laughlin MH, Ibdah JA, Thyfault JP, Rectir RS (2013) Hepatic steatosis development with 4 weeks of physical inactivity in previously active, hyperphagic OLETF rats. Am J Physiol Regul Integr Comp Physiol 304(9):R763–R771
Lindfeldt J, Balkan B, van Dijk G, Scheurink A, Ahren B, Steffens AB (1993) Influence of peri-arterial hepatic denervation on the glycemic response to exercise in rats. J Auton Nerv Syst 44(1):45–52
Lippi G, Schena F, Montagnana M, Salvagno GL, Banfi G, Guidi GC (2011) Significant variation of traditional markers of liver injury after a half-marathon run. Eur J Int Med 22(5):e36–e38
Litvinova L, Viru A (1995) Effect of exercise and adrenal insufficiency on urea production in rats. Eur J Appl Physiol 70(6):536–540
Liu J, Yeo HC, Overvik-Douki E, Hagen T, Doniger SJ, Chyu DW, Brooks GA, Ames BN (2000) Chronically and acutely exercised rats: biomarkers of oxidative stress and endogenous antioxidants. J Appl Physiol 89(1):21–28
Long D, Blake M, McNaughton L, Angle B (1990) Hematological and biochemical changes during a short triathlon competition in novice triathletes. Eu J Appl Physiol 61(1–2):93–99
Loniewski I, Sawrymowicz M, Pawlik A, Wojcicki J, Drozdzik M (2001) Lack of effect of physical exercise on pharmacokinetics of acetaminophen tablets in healthy subjects. Acta Pol Pharm 58(2):141–144
Lundbergh P, Strandell T (1974) Changes in hepatic circulation at rest, during and after exercise in young males with infectious hepatitis compared with controls. Acta Med Scand 196(4):315–325
Mager DR, Patterson C, So S, Rogenstein CD, Wykes LJ, Roberts EA (2010) Dietary and physical activity patterns in children with fatty liver. Eur J Clin Nutr 64(6):628–635
Magkos F, Patterson BW, Mohammed BS, Mittendorfer B (2007) A single 1-h bout of evening exercise increases basal FFA flux without affecting VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics in untrained lean men. Am J Physiol 292(6):E1568–E1574
Magkos F, Patterson BW, Mohammed BS, Mittendorfer B (2009) Basal adipose tissue and hepatic lipid kinetics are not affected by a single exercise bout of moderate duration and intensity in sedentary women. Clin Sci (Lond) 116(4):327–334
Malhi N, Kaufman RJ (2011) Endoplasmic reticulum stress in liver disease. J Hepatol 54(4):795–809
Malinoski FJ (1992) Strenuous exercise simulating hepatic injury during vaccine trials. Vaccine 10(1):39–42
Margaritis I, Tessier F, Richard MJ, Marconnet P (1997) No evidence of oxidative stress after a triathlon race in highly trained competitors. Int J Sports Med 18(3):186–190
Marinho R, Ropelle ER, Cintra DE, De Souza CT, Da Silva ASR, Bertoli FC, Colantonio E, D’Almeida V, Pauli JR (2012) Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss. J Cell Physiol 227(7):2917–2926
Marques CMM, Motta VF, Torres TS, Aguila MB, Mandarim-de-Lacerda CA (2010) Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice. Braz J Med Biol Res 43(5):467–475
Martin WH, Dalsky GP, Hurley BF, Matthews DE, Bier DM, Hagberg JM, Rogers MA, King DS, Holloszy JO (1993) Effect of endurance training on plasma free fatty acid turnover and oxidation during exercise. Am J Physiol 265(5 Pt 1):E708–E714
Mauriz JL, Tabernero B, Garcia-Lopez J (2000) Physical exercise and improvement of liver oxidative metabolism in the elderly. Eur J Appl Physiol 81(1–2):62–66
McMillan KP, Kuk JL, Church TS, Blair DN, Ross R (2007) Independent associations between liver fat, visceral adipose tissue, and metabolic risk factors in men. Appl Physiol Nutr Metab 32(2):265–272
Meek SE, Nair KS, Jensen MD (1999) Insulin regulation of regional free fatty acid metabolism. Diabetes 48(1):10–14
Mena P, Maynar M, Campillo JE (1996) Changes in plasma enzyme activities in professional racing cyclists. Br J Sports Med 30(2):122–124
Mencin AA, Lavine JE (2011) Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care 14(2):151–157
Mikami T, Sumida S, Ishibashi Y, Ohta S (2004) Endurance exercise training inhibits activity of plasma GOT and liver caspase-3 of mice [correction of rats] exposed to stress by induction of heat shock protein 70. J Appl Physiol 96(5):1776–1781
Miura H, Yoshimoto H, Kitamura S, Yamada H (2010) Fulminant hepatic failure accompanied by fatal rhabdomyolysis following exertional heatstroke. Clin J Gastroenterol 3:318–323
Mondon CE, Dolkas CB, Reaven GM (1980) Site of enhanced insulin sensitivity in exercise-trained rats at rest. Am J Physiol 239(3):E169–E177
Moon J, Kallman J, Winter P, Srishord M, Fang Y, Gerber L, Younossi Z (2012a) Disparities in activity level and nutrition between patients with chronic hepatitis C and blood donors. PM R 4(6):436–441
Moon MK, Cho BJ, Lee YJ, Choi SH, Lim S, Park KS, Park YJ, Jang HC (2012b) The effects of chronic exercise on the inflammatory cytokines interleukin-6 and tumor necrosis factor-α are different with age. Appl Physiol Nutr Metab 37(4):631–636
Mooy J, Arends B, Kaminade JV, Boehm R, Rahn KM, Baak MV (1986) Influence of prolonged submaximal exercise on the pharmacokinetics of verapamil in humans. J Cardiovasc Pharmacol 8(5):940–942
Moses FM (1990) The effects of exercise on the gastrointestinal tract. Sports Med 9(3):159–172
Moura LP, Puga GM, Beck WR, Teixeira IP, Ghezzi AC, Silva GA, Mello MAR (2011) Exercise and spirulina control non-alcoholic hepatic steatosis and lipid profile in diabetic Wistar rats. Lipids Health Dis 10:77 (On-line publication)
Mukherjee A, Sidis Y, Mahan A, Raher MJ, Xia Y, Rosen ED, Bloch KD, Thomas MK, Schneyer AL (2007) FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults. Proc Natl Acad Sci USA 104(4):1348–1353
Murakami T, Shimomura Y, Fujitsuka N, Sokabe M, Okamura K, Sakamoto S (1997) Enlargement glycogen store in rat liver and muscle by fructose-diet intake and exercise training. J Appl Physiol 82(3):772–775
Musso G, Cassader M, Rosina F, Gambino R (2012) Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysisof randomised trials. Diabetalogia 55(4):885–904
Nagel D, Seiler D, Franz H, Jung K (1990) Ultra-long distance running and the liver. Int J Sports Med 11(6):441–445
Nannipierri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner SM, Stern MP, Ferrannini E, Mexico Diabetes Study (2005) Liver enzymes, the metabolic syndrome, and incident diabetes the Mexico city diabetes study. Diabetes Care 28(7):1757–1762
Nathwani RA, Pais S, Reynolds TB, Kaplowitz N (2005) Serum alanine aminotransferase in skeletal muscle diseases. Hepatol 41(2):380–382
Navarro A, Gomez C, López-Cepero JM, Boveris A (2003) Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer. Am J Physiol 286(3):R505–R511
Neubauer O, König D, Kern N, Nics L, Wagner KH (2008) No indications of persistent oxidative stress in response to an ironman triathlon. Med Sci Sports Exerc 40(12):2119–2228
Newton JL, Jones DEJ, Henderson E, Kane L, Wilton K, Burt AD, Day CP (2008) Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance. Gut 57(6):807–813
Nguyen-Duy TB, Nichaman MZ, Church TS, Blair DN, Ross R (2003) Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am J Physiol 284(6):E1065–E1071
Nielsen HB, Febbraio MA, Ott P, Krustrup P, Secher NH (2007) Hepatic lactate uptake versus leg lactate output during exercise in humans. J Appl Physiol 103(4):1227–1233
Nilssen O, Forde OH, Brenn T (1990) The TromsØ study. Distribution and population determinants of gamma-glutamyl transferase. Am J Epidemiol 132(2):318–326
Nishida Y, Matsubara T, Tobina T, Shindo M, Tokuyama K, Tanaka K, Tanaka H (2010) Effect of low-intensity aerobic exercise on insulin-like growth factor-I and insulin-like growth factor-binding proteins in healthy men. Int J Endocrinol 2010.pii:452820 (On-line publication)
Nizielski SE, Arizmendi C, Shteyngarts AR, Farrell CJ, Friedman JE (1996) Involvement of transcription factor C/EBP-beta in stimulation of PEPCK gene expression during exercise. Am J Physiol 270(5 Pt 2):R1005–R1012
Noakes TD, Carter JW (1976) Biochemical parameters in athletes before and having run 160 kilometres. S Afr Med J 50(40):1562–1566
Noakes TD, Carter JW (1982) The responses of plama biochemical parameters to a 56 km race in novice and experienced ultramarathoners. Eur J Appl Physiol 49(2):179–186
Nobili V, Sanyal AJ (2012) Treatment of nonalcoholic fatty liver disease in adults and children: a closer look at the arsenal. J Gastroenterol 47(1):29–36
Nobili V, Manco M, Devito R, Di Commo V, Comparcola D, Sartorelli MR, Piemonte F, Marcellini M, Angulo P (2008) Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatol 48(1):119–128
Nobili V, Carter-Kent C, Feldstein AE (2011) The role of lifestyle changes in the management of chronic liver disease. BMC Medicine 9:70 (On-line publication)
Ochiai M, Matsuo T (2012) Increased stearoyl-CoA desaturase index and triglyceride content in the liver of rats after a single bout of swimming exercise. Biosci Biotechnol Biochem 76(7):1350–1355
O’Donovan G, Thomas EL, McCarthy JP, Fitzpatrick J, Durigfhel G, Mehta S, Morin SX (2009) Fat distribution in men of different waist girth, fitness level and exercise habit. Int J Obesity (Lond) 33(12):1356–1362
Ogonovszky H, Sasvari M, Dosek A, Berkes I, Kaneko T, Tahara S, Nakamoto H, Goto S, Radak Z (2005) The effects of moderate, strenuous and overtraining on oxidative stress markers and DNA repair in the rat liver. Can J Appl Physiol 30(2):186–195
Ohno H, Yahata T, Yamashita K, Yamamura K, Sato Y, Yamamoto C, Hayamizu S, Taniguchi N (1988) Effect of physical training on immunoreactive gamma- glutamyltransferase in human plasma. Enzyme 39(2):110–114
Orioli S, Bandinelli I, Birardi A, Chieca R, Buzzelli G, Chiarantini E (1990) Hepatic antipyrine metabolism in athletes. J Sports Med Phys Fitness 30(3):261–263
Oza N, Eguchi Y, Mizuta T, Ishibashi E, Kitajima Y, Horie H, Ushirogawa M, Tsuzura T, Nakashita S, Takahashi H, Kawaguchi Y, Oda Y, Iwakiri R, Ozaki I, Eguchi T, Ono N, Fujimoto K (2009) A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff. J Gastroenterol 44(12):1203–1208
Panton LB, Guillen GJ, Williams L, Graves JE, Vivas C, Cediel M, Pollock ML, Garzarella L, Krumerman J, Derendorf H et al (1995) The lack of effect of aerobic exercise training on propranolol pharmacokinetics in young and elderly adults. J Clin Pharmacol 35(9):885–894
Paquette AW, Wang D, Gauthier MS, Prud’homme D, Jankowski M, Gutkowska J, Lavoie JM (2007) Specific adaptations of estrogen receptor alpha and beta transcripts in liver and heart after endurance training in rats. Mol Cell Biochem 306(1–2):179–187
Park S, Hong SM, Lee JE, Sung SR (2007) Chlorpromazine exacerbates hepatic insulin sensitivity via attenuating insulin and leptin signaling pathway, while exercise partially reverses the adverse effects. Life Sci 80(26):2428–2435
Pedersen L, Pilegaard H, Hansen J, Brandt C, Adser H, Hidalgo J, Olesen J, Pedersen BK, Hojman P (2011) Exercise-induced liver chemokine CXCL-1 expression is linked to muscle-derived interleukin-6 expression. J Physiol 589(Pt 6):1409–1420
Peeling P (2010) Exercise as a mediator of hepcidin activity in athletes. Eur J Appl Physiol 110(5):877–883
Peijie C, Zicai D, Haowen X, Renbao X (2004) Effects of chronic and acute training on glucocorticoid receptors concentrations in rats. Life Sci 75(11):1303–1311
Perseghin G, Lattuada G, De Cobelli F, Ragogna F, Ntali G, Esposito A, Belloni E, Canu T, Terruzzi I, Scifo P, Del Maschio A, Luzi L (2007) Habitual physical activity is associated with intrahepatic fat content in humans. Diabetes Care 30(3):683–688
Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI (2005) Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54(3):603–608
Peterson KF, Price TB, Bergeron R (2004) Regulation of net hepatic glycogenolysis and gluconeogenesis during exercise: impact of type I diabetes. J Clin Endocrinol Metab 89(9):4656–4664
Petridou A, Nikolaidis MG, Matsakas A, Schulz T, Michna H, Mougios V (2005) Effect of exercise training on the fatty acid composition of lipid classes in rat liver, skeletal muscle, and adipose tissue. Eur J Appl Physiol 94(1–2):84–92
Pettersson J, Hindorf U, Persson P, Bengtsson T, Malmqvist U, Werkstrom V, Ekelund M (2008) Muscular exercise can cause highly pathological liver function tests in healthy men. Br J Clin Pathol 65(2):253–259
Pieber K, Crevenna R, Nuhr MJ, Quittan M, Peck-Radosavljevic M, Fialka-Moser V, Wiesinger GF (2006) Aerobic capacity, muscle strength and health-related quality of life before and after orthotopic liver transplantation: preliminary data of an Austrian transplantation centre. J Rehab Med 38(5):322–328
Pighon A, Paquette A, Barsalani R et al (2009a) Substituting food restriction by resistance training prevents liver and body fat regain in ovariectomized rats. Climacteric 12(2):153–164
Pighon A, Paquette A, Barsalania R, Chapadosa NA, Rabasa-Lhoret R, Yasari S, Prud’hommec D, Lavoie JM (2009b) Resistance training attenuates fat mass regain after weight loss in ovariectomized rats. Maturitas 64(1):52–57
Pighon A, Gutkowska J, Jankowski M, Rabasa-Lhoret R, Lavoie JM (2011) Exercise training in ovariectomized rats stimulates estrogenic-like effects on expression of genes involved in lipid accumulation and subclinical inflammation in liver. Metab Clin Exp 60(5):629–639
Pinho RA, Silva LA, Pinho CA, Scheffer DL, Souza CT, Benetti M, Carvalho T, Dal-Pizzol F (2010) Oxidative stress and inflammatory parameters after an Ironman race. Clin J Sports Med 20(4):306–311
Pintus F, Mascia P (1996) Distribution and population determinants of gamma-glutamyltransferase in a random sample of Sardinian inhabitants. ATS-SARDEGNA Research Group. Eur J Epidemiol 12(1):71–76
Podolin DA, Wills BK, Wood IO, Lopez M, Mazzeo RS, Roth DA (2001) Attenuation of age-related declines in glucagon-mediated signal transduction in rat liver by exercise training. Am J Physiol 281(3):E516–E523
Praphatsorn P, Thong-Ngam D, Kulaputana O, Klaikcaw N (2010) Effects of intense exercise on biochemical and histological changes in rat liver and pancreas. Asian Biomed 4(4):619–625
Prior SJ, Jenkins NT, Brandauer J, Weiss EP, Hagberg JM (2012) Aerobic exercise training increases circulating insulin-like growth factor binding protein-1 concentration, but does not attenuate the reduction in circulating insulin-like growth factor binding protein-1 after a high-fat meal. Metabolism 61(3):310–316
Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, Fava J, Wing RR (2010) Randomized controlled trial testing the effect of weight loss on nonalcoholic steatohepatitis (NASSH). Hepatol 51(1):121–129
Radak Z, Chung HY, Naito H, Takahashi K, Jung KJ, Kim HJ, Goto S (2004) Age-associated increase in oxidative stress and nuclear factor B activation are attenuated in rat liver by regular exercise. FASEB J 18(6):749–750
Rama R, Ibáñez J, Riera M, Prats MT, Pagés T, Palacios L (1994) Hematological, electrolyte, and biochemical alterations after a 100-km run. Can J Appl Physiol 19(4):411–420
Rao R (2009) Endotoxemia and gut barrier disease in alcoholic liver disease. Hepatol 50:638–644
Rector SR, Thyfault JP (2011) Does physical inactivity cause nonalcoholic fatty liver disease? J Appl Physiol 111(6):1828–1835
Rector RS, Thyfault JP, Laye MJ, Morris RT, Borengasser SJ, Uptergrove GM, Chakravarthy MV, Booth FW, Ibdah JA (2008) Cessation of daily exercise dramatically alters precursors of hepatic steatosis in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. J Physiol 586(Pt 17):4241–4249
Rector RS, Uptergrove GM, Morris EM, Borengasser SJ, Laughlin MH, Booth FW, Thyfault JP, Ibdah JA (2011) Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model. Am J Physiol 300(5):G874–G883
Reddy Avula CP, Ferandes G (1999) Modulation of antioxidant enzymes and lipid peroxidation in salivary gland and other tissues in mice by moderate treadmill exercise. Aging (Milano) 11(4):246–252
Reynoso E, Lavine JE (2012) NAFLD: the role of exercise in treating NAFLD. Nat Rev Gastroenterol Hepatol 9(7):368–370
Richards D, Richards R, Schofield PJ, Ross V (1979) Biochemical and haematological changes in Sydney’s the sun city-to-surf fun runners. Med J Austral 2(9):449–453
Ringseis R, Mooren FC, Keller J, Couturier A, Wen G, Hirche F, Stangl GI, Eder K, Kruger K (2011) Regular endurance exercise improves the diminished hepatic carnitine status in mice fed a high-fat diet. Mol Nutr Food Res 55(Suppl 2):S193–S202
Ritland S, Foss NE, Gjone E (1982) Physical activity and liver disease and liver function. Scand J Soc Med 29:221–226
Ritland S, Petlund CF, Knudsen T, Skrede S (1983) Improvement of physical capacity after long-term training in patients with chronic active hepatitis. Scand J Gastroenterol 18(8):1083–1087
Robinson D, Whitehead TP (1989) Effect of body mass and other factors on serum liver enzyme levels in men attending for well population screening. Ann Clin Biochem 26(Pt 5):393–400
Rodriguez B, Torres DM, Harrison SA (2012) Physical activity: an essential component of lifestyle modification in NAFLD. Nat Rev Gastroenterol Hepatol 9(12):726–731
Roecker L, Meier-Buttermilch R, Brechtel L, Nemeth E, Ganz T (2005) Iron-regulatory protein hepcidin is increased in female athletes after a marathon. Eur J Appl Physiol 95(5–6):569–571
Rohrer TR, Rizzo VF, Casar JJ, Muelbredt O, Sprengart S, Gortner L, Stierkorb E (2008) Changes in hepatic risk factors, metabolic variables, body composition, and physical fitness in obese children after a one-year weight loss program. J Pediatr Endocrinol 21(9):837–845
Romani R, De Medio GE, di Tullio S, Lapalombella R, Pirisinu I, Margonato V, Veicsteinas A, Marini M, Rosi G (2009) Modulation of paraoxonase 1 and 3 expression after moderate exercise training in the rat. J Lipid Res 50(10):2036–2045
Romijn JA, Coyle EF, Sidossis LS, Gastaldelli A, Horowitz JF, Endert E, Wolfe RR (1993) Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am J Physiol 265(3 Pt 1):E380–E391
Ropelle ER, Pauli JR, Cintra DE, Frederico MJ, de Pinho RA, Velloso LA, De Souza CT (2009) Acute exercise modulates the Foxo1/PGC-1alpha pathway in the liver of diet-induced obesity rats. J Physiol 587(Pt 9):2069–2076
Rosales XQ, Chu ML, Shilling C, Wall C, Pastores GM, Mendell JR (2008) Fidelity of gamma-glutamyl transferase (GGT) in differentiating skeletal muscle from liver damage. J Child Neurol 23(7):748–751
Rowell LB (1971) Visceral blood flow and metabolism during exercise. In: Shephard RJ (ed) Frontiers of fitness. CC Thomas, Springfield, pp 210–232
Rowell LB (1974) Human cardiovascular adjustments to exercise and thermal stress. Physiol Rev 54(1):75–159
Rowell LB (1986) Human circulation: regulation during physical stress. Oxford University, New York
Rowell LB, Blackmon JR, Bruce RA (1964) Indocyanine green clearance and estimated hepatic blood flow during mild to maximal exercise in upright man. J Clin Invest 43:1677–1690
Saengsirisuwan V, Phadungkij S, Pholpramool C (1998) Renal and liver functions and muscle injuries in Thai boxers during training and after competition. Br J Sports Med 32(4):304–308
Salo DC, Donovan CM, Davies KJ (1991) HSP70 and other possible heat shock or oxidative stress proteins are induced in muscle, heart and liver during exercise. Free Radic Biol Med 11(3):239–246
Santomauro M, Paoli-Valeri M, Fernandez M, Camacho N, Molina Z, Cicchetti R, Valeri L, Davila de Campagnaro E, Arata-Bellabarba G (2012) Enfermedad del hígado graso no alcohólico y su asociación con variables clínicas y bioquímicas en los niños y adolescentes obesos: efecto de una intervención de un año en el estilo de vida. [Non-alcoholic fatty liver disease and its association with clinical and biochemical variables in obese children and adolescents: effect of a one-year intervention on lifestyle]. Endocrinol Nutr 59(6):346–353
Schäfer S, Kantartzis K, Machann J, Venter C, Niess A, Schick F, Machicao F, Häring HU, Fritsche A, Stefan N (2007) Lifestyle intervention in individuals with normal versus impaired glucose tolerance. Eur J Clin Invest 37(7):535–543
Schoemaker RC, Burggraaf J, Cohen AF (1998) Assessment of hepatic blood flow using continuous infusion of high clearance drugs. Br J Clin Pharmacol 45(5):463–469
Schultz A, Mendonca LS, Aguila MB, Mandarim-de-Lacerda CA (2012) Swimming training beneficial effects in a mice model of nonalcoholic fatty liver disease. Exp Toxicol Pathol 64(4):273–282
Schwarz AJ, Brasel JA, Hintz RL, Mohan S, Cooper DM (1996) Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab 81(10):3492–3497
Sen CK, Marin E, Kretzschmar M, Hanninen O (1992) Skeletal muscle and liver glutathione homeostasis in response to training, exercise, and immobilization. J Appl Physiol 73(4):1265–1272
Sene-Fiorese M, Duarte FO, Scarmagnani FRR, Cheik NC, Manzoni MSJ, Nonaka KO, Rossi EA, De Oliveira Duarte ACG, Damaso AR (2009) Efficiency of intermittent exercise on adiposity and fatty liver in rats fed with high-fat diet. Obesity (Silver Spring) 16(10):2217–2222
Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, Goto T, Westerbacka J, Sovijari A, Halavaara J, Yki-Järvinen H (2007) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87(7):3023–3028
Shah K, Stufflebam A, Hilton TN, Sinacore DR, Klein S, Villareal DT (2009) Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. Obesity (Silver Spring) 17(12):2162–2168
Shapiro Y, Magazanik A, Sohar E, Reich CB (1973) Serum enzyme changes in untrained subjects following a prolonged march. Can J Physiol Pharmacol 51(4):271–276
Shephard RJ (1982) Physiology and biochemistry of exercise. Praeger Publications, New York
Shephard RJ (2013) Are the abdominal viscera important to the sport physician? Esophagus, stomach, intestines, spleen and pancreas. In: Shephard RJ et al (eds) Year book of sports medicine. Elsevier, Philadelphia
Shojaee-Moradie F, Baynes KC, Pentecost C, Bell JD, Thomas EL, Jackson NC, Stolinski M, Whyte M, Lovell D, Bowes SB, Gibney J, Jones RH, Umpleby AM (2007) Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism. Diabetologia 50(2):404–413
Slentz CA, Bateman LA, Willis LH, Shields AT, Tanner CJ, Piner LW, Hawk VH, Muehlbauer MJ, Samsa GP, Nelson RC, Huffman KM, Bales CW, Houmard JA, Kraus WE (2012) Effects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RT. Am J Physiol 301(5):E1033–E1039
Smith JE, Garbutt G, Lopes P, Tunstall Pedoe D (2004) Effects of prolonged strenuous exercise (marathon running) on biochemical and haematological markers used in the investigation of patients in the emergency department. Br J Sports Med 38(3):292–294
Socha P, Horvath A, Vajro P, Dziechciarz P, Dhawan A, Szajewska H (2009) Pharmacological interventions for non-alcoholic fatty liver disease in adults and in children: a systematic review. J Pediatr Gastroenterol Nutr 48(5):587–596
Spassiani NA, Kuk JL (2008) Exercise and the fatty liver. Appl Physiol Nutr Metab 33(4):802–807
St George A, Bauman A, Johnston A, Farrell G, Chey T, George J (2009) Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatol 50(1):68–76
Stanca CM, Bach N, Krause C, Tandon N, Freni MA, Gutierrez JA, Bodian C, Lopez J, Berk PD, Bodenheimer HC, Branch AD, Odin JA (2005) Evaluation of fatigue in US patients with primary biliary cirrhosis. Am J Gastroenterol 100(5):1104–1109
Steenivasa Baba C, Alexander G, Kalyani B, Pandey R, Rastogi S, Pandey A, Choudhuri G (2006) Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. Gastroenterol Hepatol 21(1 Pt 1):191–198
Straznicky NE, Lambert EA, Grima MT, Eikelis N, Nestel PJ, Dawood T, Schlaich MP, Masuo K, Chopra R, Sari CI, Dixon JB, Tilbrook AJ, Lambert GW (2012) The effects of dietary weight loss with or without exercise training on liver enzymes in obese metabolic syndrome subjects. Diabetes Obes Metab 14(2):139–148
Suh SH, Paik IY, Jacobs K (2007) Regulation of blood glucose homeostasis during prolonged exercise. Mol Cells 23(3):272–279
Sullivan S, Kirk E, Mittendorfer B, Patterson B, Klein S (2012) Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatol 55(6):1738–1745
Sumida KD, Donovan CM (1995) Enhanced hepatic gluconeogenic capacity for selected precursors after endurance training. J Appl Physiol 79(6):1883–1888
Sumida KD, Urdiales JH, Donovan CM (1993) Enhanced gluconeogenesis from lactate in perfused livers after endurance training. J Appl Physiol 74(2):782–787
Suzuki A, Lindor K, St Saver J, Lymp J, Mendes F, Muto A, Okada T, Angulo P (2005) Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 43(6):1060–1066
Suzuki K, Peake J, Nosaka K, Okutsu M, Abbiss CR, Surriano R, Bishop D, Quod MJ, Lee H, Martin DT, Laursen PB (2006) Changes in markers of muscle damage, inflammation and HSP70 after an Ironman triathlon race. Eur J Appl Physiol 98(6):525–534
Swartz RD, Sidell FR, Cucinell SA (1974) Effects of physical stress on the disposition of drugs eliminated by the liver in man. J Pharmacol Exp Ther 188(1):1–7
Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol 288(2):E462–E468
Takahashi Y, Fukusato T (2010) Pediatric nonalcoholic fatty liver disease: overview with emphasis on histology. World J Gastroeneterol 16(42):5280–5285
Takahashi I, Umeda T, Mashiko T, Chinda D, Oyama T, Sugawara K, Nkaii S (2007) Effects of rugby sevens matches on human neutrophil-related nonspecific immunity. Br J Sports Med 41(1):13–18
Takeshita H, Horiuchi M, Izumo K, Kawaguchi H, Arimura E, Aoyama K, Takeuchi T (2012) Long-term voluntary exercise, representing habitual exercise, lowers visceral fat and alters plasma amino acid levels in mice. Env Health Prev Med 17(4):275–284
Tamura Y, Tanaka Y, Sato F, Choi JB, Watada H, Niwa M, Kinoshita J, Ooka A, Kumashiro N, Igarashi Y, Kyogoku S, Maehara T, Kawasumi M, Hirose T, Kawamori R (2005) Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 90(6):3191–3196
Targher GB, Bellis A, Fornengo P, Ciaravella F, Pichiri I, Cavallo Perin P, Trimarco B, Marchesini G (2010) Prevention and treatment of nonalcoholic fatty liver disease. Dig Liver Dis 42(5):331–340
Tarter RE, Panzak G, Switala J, Lu S, Simkevitz HV, Thiel D (1997) Isokinetic muscle strength and its association with neuropsychological capacity in cirrhotic alcoholics. Alcohol Clin Exp Res 21(2):191–196
Terao T, Fujise T, Uchiyama S, Yamashita Y, Nakano S (1989) Effects of swimming exercise at two different water temperature on hepatic lipid and lipoprotein levels in experimental fatty liver rats. Tokai J Exp Clin Med 14(2):139–145
Terjung RL, Baldwin KM, Winder WW, Holloszy JO (1971) Glycogen repletion in different types of muscle and in liver after exhausting exercise. Am J Physiol 226(6):1387–1391
Terziyski K, Andonov V, Marinov B, Kostianev S (2008) Exercise performance and ventilatory efficiency in patients with mild and moderate liver cirrhosis. Clin Exp Pharmacol Physiol 35(2):135–140
Thamer C, Machann J, Stefan N, Haap M, Schäfer S, Brenner S, Kantartzis K, Claussen C, Schick F, Haring H, Fritsche A (2007) High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention. Obesity (Silver Spring) 15(2):531–538
Thamer C, Jürgen M, Stefan N, Schäfer SA, Machicao F, Staiger H, Laakso M, Böttcher M, Claussen C, Schick F, Fritsche A, Haring H-U (2008) Variations in PPARD determine the change in body composition during lifestyle intervention: a whole body magnetic resonance study. J Clin Endocrinol Metab 93(4):1497–1500
Theilade P, Hansen JM, Skovsted L, Kampmann JP (1979) Effect of exercise on thyroid parameters and on metabolic clearance rate of antipyrine in man. Acta Endocrinol 92(2):271–276
Thoma C, Day CP, Trenell MI (2012) Lifestyle interventions for the treatment of non- alcoholic fatty liver disease in adults: a systematic review. J Hepatol 56(1):255–266
Thomas EL, Brynes AE, Hamilton G, Patel N, Spong A, Goldin RD, Frost G, Bell JD, Taylor-Robinson SD (2006) Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease. World J Gasteroeneterol 12(36):5813–5819
Thompson WR (2010) ACSM’s gudielines for exercise testing and prescription, 8th ed, Lipppincott, Williams & Wilkins, Baltimore
Thompson PD, Cullinane EM, Sady SP, Flynn MM, Chenevert CB, Herbert PN (1991) High-density-lipoprotein metabolism in endurance athletes and sedentary men. Circulation 84(1):140–152
Thompson PD, Crouse SF, Goodpaster B, Kelley D, Moyna N, Pescatello L (2001) The acute versus the chronic response to exercise. Med Sci Sports Exerc 33(6 Suppl):S438–S445 (discussion S452–S453)
Thompson D, Markovitch D, Betts JA, Mazzatti D, Turner J, Tyrrell RM (2010) Time course of changes in inflammatory markers during a 6-mo exercise intervention in sedentary middle-aged men: a randomized controlled trial. J Appl Physiol 108(4):769–779
Thyfault JP, Rector RS, Uptergrove GM, Borengasser SJ, Morris EM, Wei Y, Laye MJ, Burant CF, Qi NR, Ridenour SE, Koch LG, Britton SL, Ibdah JA (2009) Rats selectively bred for low aerobic capacity have reduced hepatic mitochondrial capacity and susceptibility to hepatic steatosis and injury. J Physiol 587(Pt 8):1805–1816
Tiikkainen M, Beergholm R, Hakkinen AM, Bergholm R, Vehkavaara S, Halavaara J, Teramo K, Rissanen A, Yki-Järvinen H (2002) Liver fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obesity Res 10(9):859–867
Trimmer JK, Schwarz JM, Cadsazza GA, Horning MA, Rodriguez N, Brooks GA (2002) Measurements of gluconeogenesis in exercising men by mass isotopomer distribution analysis. J Appl Physiol 93(1):233–241
Tsekouras YE, Magkos F, Kellas Y, Basioukas KN, Kavouras SA, Sidossis LS (2008) High-intensity interval aerobic training reduces hepatic very low-density lipoprotein-triglyceride secretion rate in men. Am J Physiol 295(4):E851–E858
Tsuruta G, Tanaka N, Hongo M, Komatsu M, Horiuchi A, Hamamoto K, Iguchi C, Nakayama Y, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Aoyama T, Tanaka E (2010) Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits. J Gastroenterol 45(6):666–672
Turgut G, Demir S, Genc O, Karabulut I, Akalin N (2003) The effect of swimming exercise on lipid peroxidation in the rat brain, liver and heart. Acta Physiol Pharmacol Bulg 27(2–3):43–45
Turner JE, Hodges NJ, Bosch JA, Aldred S (2011) Prolonged depletion of antioxidant capacity after ultraendurance exercise. Med Sci Sports Exerc 43(9):1770–1776
Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, Torimura T, Inuzuka S, Sata M, Tanikawa K (1997) Therapeutic effect of restricted diet and exercise in obese patients with fatty liver. J Hepatol 27(1 Pt 1):103–107
van der Heijden G, Toffolo G, Manesso E, Sauer PJ, Sunehag AL (2009) Aerobic exercise increases peripheral and hepatic insulin sensitivity in sedentary adolescents. J Clin Endocrinol Metab 94(11):4292–4299
van der Heijden GJ, Wang ZJ, Chu Z, Toffolo G, Manesso E, Sauer PJ, Sunehag AL (2010a) Strength exercise improves muscle mass and hepatic insulin sensitivity in obese youth. Med Sci Sports Exerc 42(11):1973–1980
van der Heijden GJ, Wang ZJ, Chu ZD, Sauer PJ, Haymond MW, Rodriguez LM, Sunehag AL (2010b) A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents. Obesity (Silver Spring) 18(2):384–390
van Dijk G, Balkan B, Lindfeldt J, Bouws G, Scheurink AJ, Ahren B, Steffens AB (1994) Contribution of liver nerves, glucagon and adrenaline to the glycemnic r esponse to exercise in rats. Acta Physiol Scand 150(3):305–313
van Griensven JM, Burggraaf KJ, Gerloff J, Gunzler WA, Beier H, Kroon R, Huisman LG, Schoemaker RC, Kluft K, Cohen AF (1995) Effects of changing liver blood flow by exercise and food on kinetics and dynamics of saruplase. Clin Pharmacol Ther 57(4):381–389
Van Rensburg JP, Kielblock AJ, van der Linde A (1986) Physiologic and biochemical changes during a triathlon competition. Int J Sports Med 7(1):30–35
van Wijck K, Lenaerts K, van Loon LJC, Peters WHM, Buurman WS, Dejong CHC (2011) Exercise-induced splanchnic hypoperfusion results in gut dysfunction in healthy men. PLoS One 6(7):e22366
Venditti P, Di Meo S (1997) Effect of training on antioxidant capacity, tissue damage, and endurance of adult male rats. Int J Sports Med 18(7):497–502
Viitasalo A, Laaksonen DE, Lindi V, Eloranta AM, Jaaskelainen J, Tompuri T, Vaisanen S, Lakka HM, Lakka TA (2012) Clustering of metabolic risk factors is associated with high-normal levels of liver enzymes among 6- to 8-year-old children: the PANIC study. Metab Syndr Relat Disord 10(5):337–343
Villa JG, Cuadrado G, Bayón JE, González-Gallego J (1998) The effect of physical conditioning on antipyrine clearance. Eur J Appl Physiol 77(1–2):106–111
Wade OL, Bishop JM (1962) Cardiac output and regional blood flow. Blackwell Scientific, Oxford
Wahren DG, Ekberg K (2007) Splanchnic regulation of glucose production. Annu Rev Nutr 27:329–345
Wahren J, Felig P, Ahlborg G, Jorfeldt L (1971) Glucose metabolism during leg exercise in man. J Clin Invest 50(12):2715–2725
Waskiewicz Z, Klapcinska B, Sadowska-Krepa E, Czuba M, Kempa K, Kimsa E, Gerasimuk D, Waskiewicz Z, Klapcinska B, Sadowska-Krepa E, Czuba M, Kempa K, Kimsa E, Gerasimuk D (2012) Acute metabolic responses to a 24-h ultra-marathon race in male amateur runners. Eur J Appl Physiol 112(5):1679–1688
Wasserman DH, Cherrington AD (1991) Hepatic fuel metabolism during muscular work: role and regulation. Am J Physiol 260(6 Pt 1):E811–E824
Wasserman DH, Spalding JA, Lacy DB, Colburn CA, Goldstein RE, Cherrington AD (1989) Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. Am J Physiol 257(1 Pt 1):E108–E117
Wasserman DH, Connolly CC, Pagliassotti MJ (1991) Regulation of hepatic lactate balance during exercise. Med Sci Sports Exerc 23(8):912–919
Wasserman DH, Lacy DB, Bracy DP (1993) Relationship between arterial and portal vein immunoreactive glucoagon during exercise. J Appl Physiol 75(2):724–729
Wasserman DH, O’Doherty RM, Zinker BA (1995) Role of the endocrine pancreas in control of fuel metabolism by the liver during exercise. Int J Obesity Relat Metab Disord 19(Suppl 4):S22–S30
Whitfield JB (2001) Gamma glutamyl transferase. Crit Rev Clin Lab Sci 38(4):263–355
Wieczorek-Baranowska A, Nowak A, Michalak E, Karolkiewicz J, Pospieszna B, Rutkowski R, Laurentowska M, Pilaczyńska-Szcześniak L (2011) Effect of aerobic exercise on insulin, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in overweight and obese postmenopausal women. J Sports Med Phys Fitness 51(3):525–532
Wiesinger GF, Quittan M, Zimmermann K, Nuhr M, Wichlas M, Bodingbauer M, Asari R, Berlakovich G, Crevenna R, Fialka-Moser V, Peck-Radosavljevic M (2001) Physical performance and health-related quality of life in men on a liver transplantation waiting list. J Rehabil Med 33(6):260–265
Williams P, Wood P, Haskell W, Vranizan K, Ho P, Vodak P (1981) Effect of exercise intensity and duration on plasma-lipoprotein cholesterol levels. Circulation 64(4):185
Wilson PO, Johnson P (2000) Exercise modulates antioxidant enzyme gene expression in rat myocardium and liver. J Appl Physiol 88(5):1791–1796
Winnick JJ, Sherman WM, Habash DL, Stout MB, Failla ML, Belury MA, Schuster DP (2008) Short-term aerobic exercise training in obese humans with type 2 diabetes mellitus improves whole-body insulin sensitivity through gains in peripheral, not hepatic insulin sensitivity. J Clin Endocrinol Metab 93(3):771–778
Wolfe BM, Havel JR, Marliss EB, Kane JP, Seymour J, Ahuja SP (1976) Effects of a 3- day fast and of ethanol on splanchnic metabolism of ffa, amino-acids, and carbohydrates in healthy young men. J Clin Invest 57(2):329–340
Wolfe RR, Klein S, Carraro F, Weber JM (1990) Role of triglyceride fatty-acid cycle in controlling fat-metabolism in humans during and after exercise. Am J Physiol 258(2):E382–E389
Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L (2001) The cardiac response to exercise in cirrhosis. Gut 49(2):268–275
Woodruff TK, Krummen L, Chen SA, Lyon R, Hansen SE, DeGuzman G, Covello R, Mather J, Cossum P (1993) Pharmacokinetic profile of recombinant human (rh) inhibin A and activin A in the immature rat. II. Tissue distribution of [125I]rh- inhibin A and [125I]rh-activin A in immaturefemale and male rats. Endocrinology 132(2):725–734
Wu HJ, Chen KT, Shee BW, Chang HC, Huang YJ, Yang RS (2004) Effects of 24 h ultra-marathon on biochemical and hematological parameters. World J Gastroenterol 10(18):2711–2714
Wu LJ, Wu MS, Lien GS, Chen FC, Tsai JC (2012) Fatigue and physical activity levels in patients with liver cirrhosis. J Clin Nurs 21(1–2):129–138
Yang RC, Mack GW, Wolfe RR, Nadel ER (1998) Albumin synthesis after intense intermittent exercise in human subjects. J Appl Physiol 84(2):584–592
Yano L, Yano H, Taketa K (1996) Electromagnetic determination of portal venous flow in rats during exercise. Int Hepatol Comm 5(3):184–190
Yano H, Kinoshita S, Yano L (1997) Acute exercise induces mitocondria swelling of hepatocytes surrounding the terminal hepatic venule in rat liver acinus. Jpn J Phys Fitness Sports Med 46(1):49–54
Yasari S, Paquette A, Charbonneau A, Gauthier MS, Savard R, Lavoie JM (2006) Effects of ingesting a high-fat diet upon exercise-training cessation on fat accretion in the liver and adipose tissue of rats. Appl Physiol Nutr Metab 31(4):367–375
Yasari S, Wang D, Prud’homme D, Jankowski M, Gutkowska J, Lavoie JM (2009) Exercise training decreases plasma leptin levels and the expression of hepatic leptin receptor-a, -b, and, -e in rats. Mol Cell Biochem 324(1–2):13–20
Yasari S, Prud’homme D, Wang D, Jankowski M, Levy E, Gutkowska J, Lavoie J-M (2010) Exercise training decreases hepatic SCD-1 gene expression and protein content in rats. Mol Cell Biochem 335(1–2):291–299
Yiamouyiannis CA, Sanders RA, Watkins JB, Martin BJ (1992) Chronic physical activity: hepatic hypertrophy and increased total biotransformation enzyme activity. Biochem Pharmacol 44(1):121–127
Yiamouyiannis CA, Martin BJ, Walkins JB (1993) Chronic physical activity alters excretory function in rats. J Pharmacol Exp Ther 265(1):321–327
Yoneda MF, Fujita K, Iwasaki T, Maeyama S, Terauchi Y, Nakajima A (2006) Treatment of NASH: nutritional counseling and physical exercise. Nihon Rinsho 64(6):1139–1145
Zawalich W, Maturo S, Felig P (1982) Influence of physical training on insulin release and glucose utilization by islet cells. Am J Physiol 243(6):E464–E469
Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Zvibel I, Goldiner I, Blendis L, Halpern Z, Oren R (2008) Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study. Hepatol 48(6):1791–1798
Zelber-Sagi S, Ratziu V, Oren R (2011) Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol 17(29):3377–3389
Zucker DM (2004) An exercise intervention to prevent hepatitis related fatigue. Hepatol 40:511A
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Nigel A.S. Taylor.
Rights and permissions
About this article
Cite this article
Shephard, R.J., Johnson, N. Effects of physical activity upon the liver. Eur J Appl Physiol 115, 1–46 (2015). https://doi.org/10.1007/s00421-014-3031-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00421-014-3031-6